Selective distribution of pharmacy item data from pharmacy item tracking system

Information

  • Patent Grant
  • 12040065
  • Patent Number
    12,040,065
  • Date Filed
    Friday, January 6, 2023
    a year ago
  • Date Issued
    Tuesday, July 16, 2024
    4 months ago
Abstract
Methods and systems relate to providing varying levels of detail about a pharmacy item to a patient information system based on the capabilities of the patient information system. An intercept device can receive an identifier associated with a pharmacy item based on a scanner reading a computer-readable code. The intercept device can recognize or determine the storage capabilities or limitations of the patient information system, for example by determining various medication data fields that the patient information system uses to store pharmacy item information. The intercept device can use the machine readable code to obtain pharmacy item information that is compatible with the patient information system based on those storage capabilities or limitations and can distribute that pharmacy item information to the patient information system.
Description
BACKGROUND

Tracking the location, status, and/or other information regarding individual items is often beneficial. Such tracking can often be complex, as in some applications the number of individual items to be tracked can be thousands, millions, or more. As one example, in a healthcare facility, pharmacy items, such as, medications, drugs, diluents, medical and surgical supplies, gauze, scissors, needles, labels, baggies, bandages, packaging, vials, syringes, and/or other medical items for which a pharmacy is responsible, that are distributed from the pharmacy should be managed closely to conform to regulatory guidelines regarding use and waste, to avoid misadministration and diversion, and to ensure appropriate inventory management and patient billing. As another example, shipping and receiving operations process many individual items per day, routing them through various preparation, packaging, routing, shipping, and delivery stages.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a block diagram illustrating an environment for tracking items and/or selectively communicating medication data field values to a patient information system.



FIG. 2 illustrates is a data flow diagram illustrative of an example process for selectively distributing medication data field values to a patient information system.



FIG. 3 is a flow diagram illustrating an embodiment of a routine for selectively communicating medication data field values based on the medication data fields that a patient information system uses to store data.





DETAILED DESCRIPTION

Systems and methods are described herein for tracking individual items and/or selectively distributing data associated with individual items. Although various aspects of the disclosure will be described with regard to examples and embodiments, one skilled in the art will appreciate that the disclosed embodiments and examples should not be construed as limiting.


In the present disclosure, reference is made to items. As used herein, the term “item” is used broadly to define any article, person, process, or procedure that may be tracked using a tracking system. In some examples described herein, an item can be a pharmacy item.


The term “pharmacy item” is used broadly to refer to any item that is distributed from a pharmacy or otherwise used in the medical treatment of a patient in a healthcare facility. By way of non-limiting example, a pharmacy item can be a medication, drug, diluent, or other medical or surgical supply, including gauze, scissors, needles, syringes, labels, baggies, bandages, medical packaging, vials or other medical containers, or any other healthcare item. Throughout this disclosure, examples are described wherein a pharmacy item is a medication, or dose thereof, to be administered to a patient; however, these examples are not intended to be limiting, and a pharmacy item can be a non-medication healthcare item used in the treatment of a patient. However, a pharmacy item is merely a subset of the items contemplated within this application and tracking of other types of items, in other contexts, is also within the scope of this disclosure. For example, an item may refer to any package or product processed in manufacturing operation, shipping and receiving operation, storage operation, etc. Moreover, in some instances, the term item is used broadly to encompass tracking of people or animals. For example, the tracking systems described herein may be used to track a patient or healthcare professional within a healthcare facility. In some instances, item may refer to a process or procedure. For example, in the healthcare context, an item may refer to a particular test prescribed for a particular patient.


In some instances, items can contain or be associated with one or more machine-readable codes or labels, for example, barcodes (e.g., but not limited to, one-dimensional barcodes, two-dimensional barcodes, such as, QR codes, etc.), radio-frequency identification (RFID) tags, etc. For example, individual items can include a code or an RFID tag having machine-readable information such as an item identifier, intended user, or location, for example. A container such as a box, tray, or canister that includes pharmacy items can include a code or an RFID tag having machine-readable information such as a kit identifier, kit type, intended user, or location, for example.


A machine-readable code, label, or tag can include an identifier that corresponds to a particular patient with whom the item(s) is/are associated. The machine-readable code can include identifiers that correspond to product identifiers (e.g., National Drug Codes (NDC) or Universal Product Code (UPC)), lot numbers, and expiration dates. The identifiers can correspond to medications listed in a pharmacy item order, such as, NDC. In some instances, identifiers can correspond to one or more unique identifiers associated with the pharmacy items or doses thereof, which are generated by a tracking system and used to track the pharmacy item. A pharmacist or other user can verify the contents of a pharmacy item for accuracy. The identifiers or other information can be associated with the code or RFID tags in a computer database to allow subsequent identification and processing by RFID or other technology.


As used herein, the term “unique identifier” or similar term, is intended to refer to an identifier, such as an alpha-numeric identifier, that can uniquely identify an item from other items. In some cases, a unique identifier can uniquely identify an item from other items that include the same type of drug or from other items that include the same drug. In some cases, a unique identifier can uniquely identify an item from all other items. For example, an NDC is used to identify different drugs and a UPC is used to identify different products. However, an NDC is unable to identify a particular vial, syringe, bag, or dose, of one type of drug from a different vial, syringe, bag, or dose, of the same kind of drug. Similarly, a UPC is unable to identify one instance of a product from another instance of the same product. The unique identifier, however, can uniquely identify a particular vial, syringe, bag, or dose from all other vials, syringes, bags, or doses of a particular drug and other drugs or pharmacy items, and in some cases, may also be referred to as a universally unique identifier or item-specific unique identifier. Further, the unique identifier can be embedded in a machine-readable label, which may also be referred to herein as a machine-readable unique identifier. In some cases, the unique identifier only uniquely identifies an associated item within the tracking system.


A pharmacy item can be released to the healthcare facility to be administered to the patient. In some instances, the pharmacy item is released to a nursing station or other pharmacy item drop off location within a healthcare facility. From the nursing station or other pharmacy item drop off location, the pharmacy item can be picked up by a nurse, a doctor, or other healthcare professional and delivered and administered to the patient. In some instances, custody of the pharmacy item is handed off between various healthcare professionals multiple times after being received in the healthcare facility but before arriving at the patient. For this reason, it can be difficult to track a pharmacy item throughout the entire process of entry, preparation, and delivery and administration to the patient. The methods and systems described herein can allow for increased accuracy in tracking the pharmacy item in these circumstances.


When the pharmacy item is to be administered to the patient, the administering healthcare professional can scan one or more of the machine-readable labels printed on or associated with the pharmacy item. The healthcare professional can also scan one or more machine-readable codes or labels associated with the patient, for example a patient identifier encoded within a machine-readable label, which can be located on a wristband on the patient. In some instances, by scanning both a machine-readable code or label associated with a pharmacy item and a machine-readable label associated with the particular patient, the system can verify that the pharmacy item can be administered to that particular patient. For example, the system can verify that the item being administered is not expired, past its beyond-use date, or recalled/blacklisted.


Embodiments of the system described herein can be used to track items from preparation, delivery, and/or other processing steps. In some instances, the systems and methods described herein can be used to track the location and/or other status of particular items.


In some instances, at the various stages in the preparation and delivery process, machine-readable unique identifiers can be scanned to indicate particular actions, for example, arrival at a particular location, custody exchange, or administration to a patient. When scanned, a pharmacy item tracking system can update the tracking database entries to include additional information provided by the scan. For example, once the pharmacy item is delivered to a nursing station, a machine-readable unique identifier associated with the pharmacy item can be scanned to indicate that the pharmacy item has reached the nursing station. When a particular nurse, picks up the pharmacy item for delivery to the patient the pharmacy item can be scanned again and the tracking database entry can be updated to include information about which nurse has taken custody of the pharmacy item. When the pharmacy item is delivered to the patient, the machine-readable unique identifier associated with a particular pharmacy item can be scanned to indicate that the particular pharmacy item has been (or is about to be) administered to a patient. When the pharmacy item or a portion thereof is leftover, the machine-readable unique identifier associated with a particular pharmacy item can be scanned to indicate that the particular pharmacy item has been (or is about to be) returned or disposed of.


In some instances, the systems and methods as described herein can be integrated into existing systems without requiring modification of the existing systems. For example, the systems and methods described herein can intercept communication between existing hardware at the facility, parse the communication to extract item information therefrom, obtain unique identifiers associated with the item, and generate and/or update tracking database entries associated with the item, while maintaining the expected communication between existing healthcare facility hardware.


Although the preceding description has outlined an example of a tracking system at a healthcare facility and used to track pharmacy items, it will be appreciated that the tracking system need not be limited to such an application. For example, the tracking systems as described herein can be used within a healthcare facility to track non-pharmacy items. For instance, the tracking systems may be used in a healthcare facility to track wheelchairs, beds, food orders, etc. Moreover, the tracking systems can be used to track patients themselves, or to track a patient's progress through various stages of treatment. Further, the tracking systems may be used to track patient samples, for example, tissue samples, blood samples, etc., as they are processed. The tracking systems described herein also have wide applicability in non-healthcare applications. For example, the tracking systems can be employed in manufacturing operations, shipping and receiving operations, warehouse and storage operations, etc. For example, the tracking system can be used to track individual component parts as they are assembled in manufacturing process, individual packages to be shipped in a distribution network, or the location and movement of individual items within a warehouse.


In some cases, where the items to be tracked are already associated with codes that identify them uniquely, the tracking systems and methods described herein may make use of these existing codes. For example, in a hospital a patient may be assigned a unique patient code during intake. A machine-readable label including the embedded unique patient code may be affixed to the patient, for example, with a wristband. Hospital procedures may require scanning of the machine-readable label at various stages of the patient's treatment, for example, before administering medication to the patient. When the machine-readable label is scanned, information from the scan may be sent to a hospital system for processing, for example, to determine whether the medication about to be administered is recalled, past it's beyond use date, or recalled/blacklisted. The tracking system described herein can intercept this transmission, create and/or modify tracking database entries, for example, by updating an entry related to the patient's location, and then retransmit the information to the existing hospital system. Accordingly, the tracking system is able to provide additional tracking functionality using existing unique codes and machine-readable labels, without disrupting the functionality of the existing hospital systems. By co-opting existing unique codes and machine-readable labels where available, the tracking systems described herein are able to overload those codes or labels with additional tracking information.


Systems and methods will now be described in greater detail, by way of example, in reference to several embodiments shown in the figures.


Intercept Device

As described herein, a pharmacy item can include a machine readable code that can be scanned by the scanning device. In some cases, the scanning device scans the machine readable code of the pharmacy item and communicates machine readable data to a patient information system, such as an electronic medical records (EMR) computer. The patient information system can receive and store the machine readable data. In addition, the patient information system can utilize the machine readable data to lookup additional data in another database. For example, the patient information system may be able to use the database to translate a specific drug associated with the machine readable data (for example, Tylenol) into a generic drug (for example, acetaminophen).


Embodiment disclosed herein provide systems, methods, and apparatuses for implementing an intercept device to enable tracking of pharmacy items and/or selective distribution of data associated with those pharmacy items to the patient information system. The intercept device can recognize or determine the storage capabilities or limitations of the patient information system. For example, the intercept device can determine which categories of data that the patient information system uses to store pharmacy item information. And the intercept device can use the machine readable code to obtain pharmacy item information that is compatible with the patient information system based on those storage capabilities or limitations, and can distribute that pharmacy item information to the patient information system. In this way, the patient information system receives its pharmacy item information from the intercept device, without performing its own data lookup. In addition to reducing the amount of computing resources or computing time utilized by the patient information system, in some cases the intercept device has access to pharmacy item information that would otherwise be unavailable to the patient information system. This can improve the safety of the patient information system, for example, by identifying pharmacy items that are expired or recalled. Thus, the implementation of the disclosed intercept device can advantageously improve the robustness of information of the patient information system. In addition, by identifying the capabilities of the patient information system and providing it with mostly (or, in some cases, only) those categories of information that are compatible with its capabilities, the intercept device streamlines and reduces a likelihood of error during data distribution. Furthermore, in some cases, an intercept device can be integrated into an existing healthcare system, thereby limiting costs associated with a system replacement.


An intercept device can act as an intermediary between a scanning device and a patient information system by receiving an identifier from the scanning device and distributing data to the patient information system. For example, the intercept device can receive an identifier associated with a pharmacy item from a scanning device. The intercept device can use the identifier to gather medication data field values for the particular pharmacy item and then can distribute some or all of those medication data field values to the patient information system. By providing the patient information system with medication data field values (instead of, or in addition to, the identifier received from the scanning device), the intercept device advantageously reduces the processing and/or tasks required by the patient information system, since the patient information system does not need to perform its own data lookup using the identifier.


Furthermore, in some instances, the intercept device can determine which medication data fields the patient information system uses to store medication data field values. For example, the intercept device can query the patient information system to determine which medication data fields that the patient information system uses to store information. As another example, the intercept device can determine the medication data fields, based on the type, manufacturer, version or other information about the patient information system. In some cases, this information may be stored in a lookup table. The intercept device can then distribute those medication data field values (and, in some cases, only those medication data fields) that the patient information system is configured to store. In this way, the intercept device provides the patient information system with information that the patient information system is configured to store (e.g., based on the capabilities of the patient information system). In some cases, intercept device distributes one or more medication data field values that the patient information system is not configured to store. In some such cases, the patient information system can ignore or regard some or all of those medication data field values, or can create additional data fields for those medication data field values.


Environment Overview


FIG. 1 is a block diagram illustrating an environment 100 for tracking items and/or selectively communicating medication data field values to a patient information system 120. In the illustrated embodiment, the environment 100 includes a scanning device 110, a patient information system 120, an intercept device 130, and a tracking system 140. The tracking system 140 includes a tracking database 142. Fewer or more devices or systems can be used in the environment 100 as desired.


Some or all of the scanning device 110, the patient information system 120, the intercept device 130, or the tracking system 140 can be communicatively coupled, for example, via a wired or wireless network. The network can include a local area network, for example, a private network, or a wide area network, including, for example, the Internet. In certain embodiments, some or all of the scanning device 110, the patient information system 120, the intercept device 130, or the tracking system 140 can form part of a single device and communicate via a computer bus. Regardless of the configuration, each separate device can include one or more processors and a computer-readable medium that stores specific computer-executable instructions for carrying out the operations described herein.


The scanning device 110 can be any device configured to scan machine-readable codes, labels, or tags and retrieve machine-readable data therefrom. For example, the scanning device 110 can be an RFID reader or RFID reading station. As another example, the scanning device 110 can include a barcode reader. For example, the scanning device 110 can include a one-dimensional barcode reader or a two-dimensional barcode reader, such as a QR code reader. The scanning device 110 can include a light source, such as a laser, that emits light and a light detector, such as a photodiode, to detect light reflected from the barcode or other machine-readable code. The scanning device 110 can use the detected light to determine the machine-readable data from the barcode or other machine-readable code. In certain embodiments, the scanning device 110 can include an image sensor, such as a charge-coupled device (CCD) image sensor or a complementary metal-oxide semiconductor (CMOS) image sensor. The image sensor can capture an image of the barcode or other machine-readable code, and the scanning device 110 can parse the captured image to extract the machine-readable data. The scanning device 110 can include an RFID tag reader. For example, the scanning device 110 can include or control an antenna that emits a radio frequency signal, which causes an RFID tag to respond with machine-readable data. The machine-readable data can be used to track an item at various preparation, transport, or other processing stages, or a set of items at various preparation, transport, or other processing stages.


The machine-readable data can include any type of data, such as a unique identifier, generic identifier, National Drug Code (NDC), Universal Product Number (UPC), patient data, drug data, etc. In some instances, the scanning device 110 can include a communication interface whereby the scanning device 110 can communicate the machine-readable data to other devices in the environment 100, such as, the patient information system 120 or the intercept device 130. The communication interface may allow the scanning device 110 to communicate wireless or via a wired connection.


In some instances, the scanning device 110 can be associated with a particular person. For example, the scanning device 110 can be associated with a healthcare professional, such as a nurse or doctor. In some instances, the scanning device 110 can be associated with a particular location. For example, the scanning device 110 can be associated with a processing station, a nursing station, or patient's room. In some instances, the scanning device 110 may not be associated with a particular location or person. Rather, machine-readable codes can be associated with locations or people and used to associate particular scans with particular locations or people.


As an example, a scanning device 110 at a nursing station can scan a machine-readable code or label that includes an embedded unique identifier associated with an item. The scanning device 110 can interpret machine-readable data (which can include, for example, the unique identifier) from the machine-readable code or label. This data can be sent to a tracking system and used to indicate that the item has been received at the nursing station.


As another example, a particular nurse or other healthcare professional can scan a machine-readable code including a unique identifier associated with an item to indicate that the particular nurse or other healthcare professional is taking custody of the item (e.g., to deliver the item to the patient), or to indicate that the particular dose is being administered to the patient, etc.


The patient information system 120 can include a computing device used to enter, generate, receive, and/or otherwise process an item. The patient information system 120 can be implemented as personal computer, including a desktop or laptop, a tablet, a mobile phone, or other portable computing device. The computing device can be implemented as a server, or similar networked processing device, that receives and processes an item entered by a remote user. The patient information system 120 can include a computer-readable medium storing computer executable instructions that when executed, enable a computing device to generate, receive, and/or process the item. In some cases, the patient information system 120 can communicate with a printer to print a label or tag for an item, or print an item order. For example, the patient information system 120 can generate a print file, which is sent to the printer and the printer can print the label, tag, or item order based on the print file.


The patient information system 120 can include a database such as a database for electronic medical records (EMRs). EMRs can be a digital version of the paper charts in the clinician's office, or can include patient data, medical history data, treatment history data, or the like.


The database can store, or be configured to store, medication data field values that correspond to a particular set of medication data fields (sometimes referred to as categories of data). The medication data fields can include, but are not limited to, drug name, dosage, hospital, bin number, expiration dates, NDC, UPC, GS1 barcode, location, patient or recipient information, recall information, use-by date, identifier for healthcare provider that is/was in possession of it, or the like. In some cases, the patient information system 120 stores the same medication data fields for each pharmacy item for which it stores data. For example, for each pharmacy item, the patient information system 120 can store one or more medication data field values for each medication data field it includes. However, in some cases, the patient information system 120 stores the different medication data fields for different pharmacy items.


Each medication data field can include one or more medication data field values. For example, a medication data field can include medication data field values for a plurality of pharmacy items. As an example, a medication data field “drug name” can include medication data field values of “Tylenol,” “Propofol,” “Fentanyl,” etc.


In some cases, the patient information system 120 stores a limited number or particular set of medication data fields. The particular set of medication data fields that the patient information system 120 stores can be based on any number of factors including, but not limited to, the capabilities of the patient information system 120, its manufacturer, version, or the data available to the patient information system 120. For example, capabilities of the patient information system 120 may limit the categories, amount, types, etc. of information that the patient information system 120 can receive, store, and/or process. As a non-limiting example, in some cases, capabilities of the patient information system 120 may limit it to receiving, storing, or processing NDC numbers. In some such cases, communicating medication data field values that do not correspond to the medication data field of “NDC number” may be ignored, discarded, cause an error, etc.


The intercept device 130 can form part of the patient information system 120 or the scanning device 110, or can be located along the communication pathway between the patient information system 120 and the scanning device 110. The intercept device 130 can be configured with computer-executable instructions to receive or intercept the machine-readable data extracted from the machine-readable code or label, for example before any data is provided to the patient information system 120. The intercept device 130 can be configured with computer-executable instructions to parse the machine-readable data.


The intercept device 130 can identify which medication data fields that the patient information system 120 uses to store medication data field values. This can be accomplished using any of various techniques. For example, the intercept device 130 can query the patient information system 120 to request an indication of the medication data fields is uses. In some instances, the intercept device 130 can query the patient information system 120 by providing the patient information system 120 with the unique identifier. In response to the query, or in some cases without receiving the query, the patient information system 120 can communicate an indication of the categories it uses.


As another example, the intercept device 130 may be able to consult a lookup table to identify which medication data fields that the patient information system 120 uses to store medication data field values. For example, the intercept device 130 may have previously communicated with the patient information system 120, identified the categories, and stored an indication of the categories in a lookup table or other storage.


The intercept device 130 can identify the medication data fields that the patient information system 120 uses, or is configured use, to store data at any time, such as before, after, or while concurrently receiving the machine-readable data from the scanning device 110. For example, the intercept device 130 can be configured to determine the medication data fields or medication data field values accepted by the patient information system 120 as part of a set up procedure and/or prior to the scanning device 110 performing a scan.


The intercept device 130 can communicate a request to the tracking system 140 for the medication data field values that correspond to the medication data fields that the intercept device identified as being used by the patient information system 120. The request to the tracking system 140 can include an identifier of the medication data fields and a pharmacy item identifier. For example, the request can include some or all of the machine-readable data, such as a unique identifier, that the intercept device 130 receives from the scanning device 110. The intercept device 130 can relay the medication data field values received from the tracking system 140 to the patient information system 120. In addition or alternatively, the intercept device 130 can instruct the tracking system 140 to communicate the medication data field values to the patient information system 120.


As an example, if the intercept device 130 determines that the patient information system 120 uses only three medication data fields (for example, NDC, drug name, and expiration date), then the intercept device 130 can determine to query the tracking system 140 for medication data field values that correspond to at least those (or, in some cases, only those) three medication data fields. As a corollary, if the intercept device 130 determines that the patient information system 120 does not include a medication data field corresponding to expiration date, then the intercept device 130 can determine not to query the tracking system 140 for medication data field values that correspond to the expiration date. In this way, the intercept device 130 can dynamically determine which medication data fields that the patient information system 120 uses, thereby identifying which data to communicate to the patient information system 120 or which information to refrain from communicating to the patient information system 120.


The tracking system 140 can include information linking individual items with corresponding generic identifiers. For example, the tracking system 140 may include entries that relate a particular medication to its corresponding NDC or the tracking system 140 may include a tracking database 142 or NDC database. As another example, the tracking system 140 can include entries that relate the trade items with corresponding UPCs, GS1 barcodes, etc. The tracking system 140, the intercept device 130, or the patient information system 120 can be communicatively coupled to a generic identifier database, such as an NDC database.


In some instances, the tracking system 140 is separate from the intercept device 130. In some instances, the intercept device 130, and the tracking system 140 can be integrated into a single device. In some instances, the tracking system 140 is remotely located from the intercept device 130 or the other components in the environment 100. In some instances, the tracking system 140 is locally located relative to the intercept device 130 or the other components in the environment 100.


The tracking system 140 can use the request received from the intercept device 130 to update entries in the tracking database 142 or verify information related to the item. For example, the tracking system 140 can identify the unique identifier from the request and can track an item using the unique identifier.


The tracking system 140 can use the request received from the intercept device 130 to select medication data field values that both correspond to the particular pharmacy item associated with the unique identifier and correspond to the medication data fields identified as being used by the patient information system 120. For example, based on the request from the intercept device 130, the tracking system 140 can identify data corresponding to one or more entries in the tracking database 142.


The tracking system 140 can be configured to perform verifications. For example, where the item includes a medication to be administered to a patient, the tracking system 140 may verify that the particular medication is safe to be administered to a patient. For example, the tracking system 140 may verify pharmacy items by checking for expired or soon-to-be expired medications (for example, based on manufacturer's expiration date or other beyond-use dates), checking for recalled (or otherwise blacklisted) medications, etc. In some instances, when the tracking system 140 indicates that the particular medication is not safe to be administered to the patient, (for example, if the patient is allergic to the medication), the tracking system 140 can provide a notification (for example, an alarm) that the medication should not be administered.


The scanning device 110, intercept device 130, and tracking system 140 can be used together, to track items at various preparation, transport, or other processing stages. Additionally, in some instances, the intercept device 130 and the tracking system 140 can be integrated into existing systems. For example, where a facility already includes scanning devices 110 which are configured to communicate with the patient information systems 120, an intercept device 130 and tracking system 140 as described herein can be integrated into the existing system and provide additional functionality.


In some cases, the intercept device 130 and/or tracking system 140 are integrated into the patient information system 120. For instance, the intercept device 130 can include software that is running on the patient information system 120, for example, along with EMR software, and can intercept some or all keystrokes of the patient information system 120 and analyzes them. The scanning device 110 can scan the machine readable code of the pharmacy item and can communicate the machine readable data as keystrokes, for example, since barcode readers can imitate a keyboard.


The scanning device 110 can imitate or correspond to a keyboard and the intercept device 130 can intercept or receive the “keystrokes” corresponding to that keyboard. The intercept device 130 can identify keystrokes received by the patient information system 120. For example, if the intercept device 130 determines that the keystrokes correspond to regular typing, the intercept device 130 can pass those keystrokes along to whatever application has focus and is listening for them. This would allow, for example, a doctor to type notes in a patient's record. Alternatively, if the intercept device 130 determines that the keystrokes correspond to a unique identifier, then the intercept device 130 can capture the keystroke sequence. In some cases, the intercept device 130 can prevent the keystrokes events from passing to another application running on the patient information system 120. The intercept device 130 can look up the unique identifier, for example by communicating the unique identifier to the tracking database 142 of the tracking system 140.


In some cases, the intercept device 130 or the tracking system 140 can identify or determine a generic identifier (for example, a GTIN including the NDC) associated with the unique identifier, and can communicate a sequence of keystrokes to the focus application (for example, the EMR) on the patient information system 120 imitating those keystrokes. In some cases, rather than, or in addition to, identifying a generic identifier, the intercept device 130 or the tracking system 140 can determine types of data that the patient information system 120 is capable of accepting, and can provide the patient information system 120 with pharmacy item data corresponding to those types of data.


In some cases, the intercept device 130 and/or tracking system 140 can be integrated into, or run on, the scanning device 110. In some such cases, the intercept device 130 or the tracking system 140 can identify or determine the sequence of keystrokes associated with a unique or generic identifier, and can communicate those keystrokes to the patient information system 120. The patient information system 120 can interpret the keystrokes as a regular barcode scan, for example.


Example Data Flow Diagram


FIG. 2 illustrates is a data flow diagram 200 illustrative of an example process for selectively distributing medication data field values to a patient information system 120. Although FIG. 2 only shows interactions between the scanning device 110, patient information system 120, intercept device 130, and tracking system 140, the environment 200 can include fewer or more components as desired, or can be configured differently. For example, additional communications can occur between any of the scanning device 110, patient information system 120, intercept device 130, and tracking system 140, or additional components can be used for communication.


At (1), the scanning device 110 scans one or more machine-readable codes, labels, or tags and retrieves machine-readable data. As described herein, the machine-readable data can include any type of data, such as a unique identifier, a generic identifier, a National Drug Code (NDC), a Universal Product Number (UPC), patient data, drug data, or the like. The machine-readable data can correspond to a particular medication or item, a particular type of medication, a particular dose of a medication, a particular patient, a particular healthcare professional, a particular location, or the like. The scanning device 110 can communicate at least some of the machine-readable data after the scan.


At (2), the intercept device 130 receives the machine-readable data. The intercept device 130 can receive the machine-readable data from the scanning device 110 or the patient information system 120. In some cases, the intercept device 130 intercepts the machine-readable data from communications between the scanning device 110 and the patient information system 120. The intercept device 130 can receive the machine-readable data from the scanning device 110 via a local bus, such as when the intercept device 130 and the scanning device 110 form part of a single device or via a network, such as when the intercept device 130 and the scanning device 110 are distinct devices.


The intercept device 130 can be configured with computer-executable instructions to parse the machine-readable data, for example, to extract or determine the unique identifier. For example, the unique identifiers can be embedded into machine-readable codes or labels. In addition or alternatively, the machine-readable data can be the unique identifier. In some cases, the intercept device 130 can generate the unique identifier, for example, based on the machine-readable data received from the scanning device 110. For instance, the intercept device 130 can associate unique identifiers with items based on the machine-readable data.


At (3), the intercept device 130 identifies the categories of data that the patient information system 120 uses to store data. As described herein, the patient information system 120 can include a database that stores multiple categories of data for various pharmacy items. The categories, which can be referred to as medication data fields, can include, but are not limited to, drug name, dosage, hospital, bin number, expiration dates, NDC, UPC, GS1 barcode, location, patient or recipient information, recall information, use-by date, or the like. In some cases, the patient information system 120 stores the same categories of data for each pharmacy item on which it stores data. For example, for each pharmacy item, the patient information system 120 can store one or more values (generally referred to as medication data field values) for each category of data that it stores. In some cases, the patient information system 120 stores the different categories of data for different pharmacy items. In some such cases, the intercept device 130 can identify the medication data fields that the patient information system 120 is uses to store medication data field values for the pharmacy item that corresponds to the unique identifier.


The intercept device 130 can identify the categories of data that the patient information system 120 is uses to store data using any of various techniques. For example, the intercept device 130 can query the patient information system 120 to request an indication of the categories. In some instances, the intercept device 130 can query the patient information system 120 by providing the patient information system 120 with the unique identifier. In response to the query, or in some cases without receiving the query, the patient information system 120 can communicate an indication of the categories it uses. As another example, to identify the categories the intercept device 130 can consult a lookup table. For example, the intercept device 130 may have previously communicated with the patient information system 120, identified the categories, and stored an indication of the categories in a lookup table or other storage.


At (4), the intercept device 130 communicates a request for medication data field values that correspond to the categories identified at step (3) to the tracking system 140. The request can identify the pharmacy item that corresponds to the unique identifier. For example, the request can include the unique identifier or other indication of the pharmacy item. In some cases, the request can indicate the categories identified at step (3). In some cases, the request may not indicate the categories. For example, the intercept device 130 can be configured to filter out or ignore any medication data field values received from the tracking system 140 that do not correspond to the categories identified at step (3).


The intercept device 130 can communicate the request to the tracking system 140 via a local bus, such as when the intercept device 130 and the tracking system 140 form part of a single device or via a network, such as when the intercept device 130 and the tracking system 140 are distinct devices.


At (5), the tracking system 140 communicates medication data field values to the intercept device 130. The tracking system 140 can receive the request from the intercept device 130 and can identify the medication data field values based on the request. For example, the tracking system 140 can identify those medication data field values that correspond to the unique identifier and correspond to the medication data field used by the patient information system 120. In some cases, the tracking database 142 can use the unique identifier to identify a generic identifier that corresponds to the unique identifier. The generic identifier can be used by the patient information system 120 to obtain additional data from another database, such as an NDC database.


At (6), the intercept device 130 communicates at least some of the medication data field values it received at step (5) to the patient information system 120. In some cases, the intercept device 130 communicates only medication data field values that it has determined are used by the patient information system 120.


In some cases, the intercept device 130 communicates at least one medication data field value that corresponds to a medication data field that the patient information system 120 does not use. In some such cases, the patient information system 120 may discard or ignore those medication data field values as superfluous. In this way, the patient information system 120 can filter or select the medication data field values that correspond to medication data fields that the patient information system 120 uses. In some cases, the patient information system 120 may expand its database to include one or more additional medication data fields so that it can store the those additional medication data field values.


As a non-limiting example, if the intercept device 130 determines that the patient information system 120 includes medication data fields for UPC and drug name, but does not include a medication data field for expiration date, then the intercept device 130 may selectively request medication data field values for UPC and drug name from the remotely located database, without making a request for medication data field values corresponding to expiration date.


In certain embodiments, any interactions (1)-(6) may be omitted, occur concurrently, or occur in a different order, as desired. For example, the intercept device 130 can identify the categories of data accepted by the patient information system 120 prior to, or concurrently with, any of interactions (1) or (2). Furthermore, it will be understood that fewer, more, or different interactions may occur as part of the data flow diagram 200. For example, in some cases, the tracking system 140 can update or create database entries associated with the pharmacy item in the tracking database 142 to indicate that the pharmacy item has reached a particular location, has been placed in the custody of a particular person, or has entered or completed a particular processing step. For instance, the tracking system 140 can use the request to update or create database entry indicating that a dose is being administered to the patient.


As another example, in some cases, the tracking system 140 can verify the particular item based on the request. For example, the unique identifier can be used to ensure that a particular pharmacy item or dose of a pharmacy item is at a correct location within a healthcare facility (for example, at a correct nursing station in route to a patient or in the proper patient's hospital room), that custody of the pharmacy item or dose of a pharmacy item has been given to a proper healthcare professional, (for example, a nurse assigned to the particular patient for whom the pharmacy item has been prepared), that any timing requirements associated with the pharmacy item or dose of a pharmacy item are met, (for example, ensure that medications are timely administered to the patient), that the pharmacy item or dose of a pharmacy item is administered to the correct patient, or that the pharmacy item or dose of a pharmacy item is safe for administration to the patient, (for example, by checking expiration dates, beyond use dates, and blacklist/recall statuses). Other verifications can also be performed.


As another example, the intercept device 130 or the tracking system 140 one or more safety and inventory checks. For instance, the intercept device 130 or the tracking system 140 can verify whether the medication corresponding to the pharmacy item 302 may be expired, have exceeded it's beyond use dating, or be flagged as a recalled/blacklisted item. In some cases, if the intercept device 130 or the tracking system 140 determines one or more safety and inventory check errors, the intercept device 130 or the tracking system 140 can cause an alert, for example to the patient or caregiver, or prevent an action, for example by not passes the keystrokes on to another application (e.g., an EMR) of the patient information system 120.


Flow Diagram


FIG. 3 is a flow diagram illustrating an embodiment of a routine 300 for selectively communicating medication data field values based on the medication data fields that a patient information system 120 uses to store data. In this way, the intercept device 130 can provide varying levels of detail about a pharmacy item to the patient information system based on the capabilities or configuration of the patient information system 120. One skilled in the relevant art will appreciate that the elements outlined for routine 300 can be implemented by one or more computing devices that are associated with the environment 100, including, but not limited to, the scanning device 110, the patient information system 120, the intercept device 130, the tracking system 140, or any combination thereof. For simplicity, routine 300 has been associated as being generally performed by the intercept device 130. However, the following illustrative embodiments should not be construed as limiting.


At block 305, the intercept device 130 receives an identifier. The identifier can be part of machine-readable data retrieved by a scanning device 110 after it scans one or more machine-readable codes, labels, or tags. In some cases, the intercept device 130 receives the identifier, or the machine-readable data including the identifier, as part of communications from the scanning device 110 to the intercept device 130. In some cases, the intercept device 130 receives the identifier by intercepting communications between the scanning device 110 and the patient information system 120. As described, the can correspond to, among other things, a particular drug, a particular type of drug, a particular medicinal container including a particular drug, or a particular medical container including a particular type of drug. Further, the identifier can uniquely identify a medicinal container from other medicinal containers that include the same drug or same type of drug or can uniquely identify a medicinal container from all other medicinal containers.


At block 310, the intercept device 130 determines one or more medication data fields that a patient information system 120 uses to store data. As described herein, the patient information system 120 can include a database, such as a database for electronic medical records (EMRs), and the database can use a particular set of medication data fields for storing medication data field values. In some cases, the patient information system 120 uses the same medication data fields for each item. In some cases, the patient information system 120 may use different same medication data fields for different items. In some such cases, the intercept device 130 can determine the one or more medication data fields that the patient information system uses to store medication data field values for the particular item that corresponds to the unique identifier.


The intercept device 130 may determine the one or more medication data fields that a patient information system 120 uses to store data using any of various techniques. For example, the intercept device 130 can query the patient information system 120 to request an indication of the one or more medication data fields. In some instances, the intercept device 130 can query the patient information system 120 by providing the patient information system 120 with the unique identifier. In response, the patient information system 120 can communicate an indication of the medication data fields it uses to store data, such as the more medication data fields it uses to store medication data field values for the particular item that corresponds to the unique identifier.


As another example, the intercept device 130 can consult a lookup table to determine the medication data fields. For example, the intercept device 130 may have previously communicated with the patient information system 120 and may already know which medication data fields the patient information system 120 uses to store data and/or is capable of receive.


The intercept device 130 can identify the medication data fields that the patient information system 120 uses, or is configured use, to store data at any time, such as before, after, or while concurrently receiving the machine-readable data from the scanning device 110. For example, the intercept device 130 can be configured to determine the medication data fields or medication data field values accepted by the patient information system 120 as part of a set up procedure and/or prior to the scanning device 110 performing a scan.


At block 315, the intercept device 130 queries a remotely located database for one or more medication data field values associated with the one or more medication data fields determined at block 310. In some cases, the data is stored locally.


As a non-limiting example, the remotely located database may include medication data fields for UPC, drug name, and expiration date. If the intercept device 130 determines that the patient information system 120 includes medication data fields for UPC and drug name, but does not include a medication data field for expiration date, then the intercept device 130 may selectively request medication data field values for UPC and drug name from the remotely located database, without making a request for medication data field values corresponding to expiration date.


In some cases, the intercept device 130 may request and/or the remotely located database may communicate medication data field values that do not correspond to medication data fields that the patient information system 120 uses or is configured to use. In some such cases, the intercept device 130 may discard or ignore those medication data field values as superfluous. In this way, the intercept device 130 can filter the medication data field values that correspond to medication data fields that the patient information system 120.


At block 320, the intercept device 130 receives one or more medication data field values corresponding to the query. In some cases, the intercept device 130 may receive medication data field values that do not correspond to medication data fields that the patient information system 120 uses or is configured to use. In some such cases, the intercept device 130 may discard or ignore those medication data field values as superfluous. In this way, the intercept device 130 can filter or select the medication data field values that correspond to medication data fields that the patient information system 120 uses.


At block 325, the intercept device 130 communicates the one or more medication data field values to the patient information system 120. In some cases, the intercept device 130 may communicate medication data field values that do not correspond to medication data fields that the patient information system 120 uses or is configured to use. In some such cases, the patient information system 120 may discard or ignore those medication data field values as superfluous. In this way, the patient information system 120 can filter or select the medication data field values that correspond to medication data fields that the patient information system 120 uses.


It will be understood that the various blocks described herein can be implemented in a variety of orders, and that the intercept device 130 can implement one or more of the blocks concurrently and/or change the order, as desired. For example, the intercept device 130 determine that medication data fields that the patient information system uses prior to, or concurrently with, receiving the identifier. Furthermore, it will be understood that fewer, more, or different blocks can be used as part of the routine 800. For example, the routine 1600 can include blocks for querying the patient information system 120 to determine which medicate data fields it uses.


Example Embodiments

Various examples of methods and systems for selectively communicating medication data field values to a patient information system can be found in the following clauses:


Clause 1. A method comprising:

    • receiving, from a scanning device, a first identifier corresponding to a computer-readable code associated with a medicinal container including a particular medication, wherein the first identifier uniquely identifies the medicinal container from other medicinal containers;
    • determining one or more medication data fields that a patient information system uses to store one or more medication data field values for the particular medication, wherein the patient information system is communicatively coupled with the scanning device;
    • querying, based at least in part on the first identifier, a remotely located database for the one or more medication data field values for the particular medication;
    • receiving the one or more medication data field values for the particular medication; and
    • communicating the one or more medication data field values to the patient information system.


Clause 2. The method of clause 1, wherein the first identifier uniquely identifies the medicinal container from other medicinal containers that include the same type of drug.


Clause 3. The method of any of the previous clauses, wherein the first identifier uniquely identifies the medicinal container from other medicinal containers that include the same drug.


Clause 4. The method of any of the previous clauses, wherein the scanning device comprises an RFID reader.


Clause 5. The method of any of the previous clauses, wherein the scanning device comprises a barcode scanner.


Clause 6. The method of clause 5, wherein the computer-readable code is a one-dimensional barcode or a two-dimensional barcode.


Clause 7. The method of any of the previous clauses, wherein said querying the remotely located database comprises transmitting the first identifier to a remotely-located tracking system.


Clause 8. The method of clause 7, wherein the remotely-located tracking system is configured to:

    • identify the one or more medication data field values for the particular medication based at least in part on the first identifier, and
    • communicate the one or more medication data field values.


Clause 9. The method of any of the previous clauses, wherein said determining one or more medication data fields comprises querying the patient information system database for the one or more medication data fields.


Clause 10. The method of any of Clauses 7-9, wherein the remotely-located tracking system is configured to update location information associated with the particular medication.


Clause 11. The method of any of the previous clauses, wherein the medication data field values comprise an NDC number.


Clause 12. The method of any of the previous clauses, wherein the medication data field values comprise a name of the particular drug.


Clause 13. The method of any of the previous clauses, wherein the medication data field values comprise recall information.


Clause 14. The method of any of the previous clauses, wherein the medication data field values comprise at least one of a use-by date or an expiration date.


Clause 15. The method of any of the previous clauses, wherein the patient information system is an electronic medical records database.


Clause 16. A system comprising:

    • an intercept device communicatively coupled along a communication pathway between a scanning device and a patient information system, the intercept device comprising a processor configured to:
    • receive, from the scanning device, a first identifier corresponding to a computer-readable code associated with a medicinal container including a particular medication, wherein the first identifier uniquely identifies the medicinal container from other medicinal containers;
    • determine one or more medication data fields that the patient information system uses to store one or more medication data field values for the particular medication, wherein the patient information system is communicatively coupled with the scanning device;
    • query, based at least in part on the first identifier, a remotely located database for the one or more medication data field values for the particular medication;
    • receive the one or more medication data field values for the particular medication; and
    • communicate the one or more medication data field values to the patient information system.


Clause 17. The system of clause 16, wherein the first identifier uniquely identifies the medicinal container from other medicinal containers that include the same type of drug.


Clause 18. The system of any of clauses 16 or 17, wherein the first identifier uniquely identifies the medicinal container from other medicinal containers that include the same drug.


Clause 19. The system of any of clauses 16 to 18, wherein the scanning device comprises an RFID reader.


Clause 20. The system of any of clauses 16 to 19, wherein the scanning device comprises a barcode scanner.


Clause 21. The system of clause 20, wherein the computer-readable code is a one-dimensional barcode or a two-dimensional barcode.


Clause 22. The system of any of clauses 16 to 21, wherein said querying the remotely located database comprises transmitting the first identifier to a remotely-located tracking system.


Clause 23. The system of clause 22, wherein the remotely-located tracking system is configured to:

    • identify the one or more medication data field values for the particular medication based at least in part on the first identifier, and
    • communicate the one or more medication data field values.


Clause 24. The system of clause 22, wherein to determine the one or more medication data fields, the intercept device is configured to query the patient information system database for the one or more medication data fields.


Clause 25. The system of clause 22, wherein the remotely-located tracking system is configured to update location information associated with the particular medication.


Clause 26. The system of any of clauses 16 to 25, wherein the medication data field values comprise an NDC number.


Clause 27. The system of any of clauses 16 to 26, wherein the medication data field values comprise a name of the particular drug.


Clause 28. The system of any of clauses 16 to 27, wherein the medication data field values comprise recall information.


Clause 29. The system of any of clauses 16 to 28, wherein the medication data field values comprise at least one of a use-by date or an expiration date.


Clause 30. The system of any of clauses 16 to 29, wherein the patient information system is an electronic medical records database.


Clause 31. The system of any of clauses 16 to 30, wherein to receive the first identifier, the intercept device is configured to intercept a communication from the scanning device to the patient information system.


Clause 32. The system of any of clauses 16 to 31, wherein the remotely located database stores medication data field values associated with a plurality of medication data fields, wherein the one or more medication data fields that the patient information system uses to store the one or more medication data field values for the particular medication includes some but not all of the plurality of medication data fields.


Additional Considerations

Conjunctive language such as the phrase “at least one of X, Y and Z,” unless specifically stated otherwise, is otherwise understood with the context as used in general to convey that an item, term, etc. may be either X, Y or Z. Thus, such conjunctive language is not generally intended to imply that certain embodiments require at least one of X, at least one of Y and at least one of Z to each be present.


Conditional language, such as, among others, “can,” “could,” “might,” or “can,” unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements, and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without user input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular embodiment.


Unless the context clearly requires otherwise, throughout the description and the claims, the words “comprise,” “comprising,” and the like are to be construed in an inclusive sense, as opposed to an exclusive or exhaustive sense; that is to say, in the sense of “including, but not limited to.” As used herein, the terms “connected,” “coupled,” or any variant thereof means any connection or coupling, either direct or indirect, between two or more elements; the coupling or connection between the elements can be physical, logical, or a combination thereof. Additionally, the words “herein,” “above,” “below,” and words of similar import, when used in this application, refer to this application as a whole and not to any particular portions of this application. Where the context permits, words in the above detailed description using the singular or plural number can also include the plural or singular number respectively. The word “or” in reference to a list of two or more items, covers all of the following interpretations of the word: any one of the items in the list, all of the items in the list, and any combination of the items in the list. Likewise, the term “and/or” in reference to a list of two or more items, covers all of the following interpretations of the word: any one of the items in the list, all of the items in the list, and any combination of the items in the list.


Depending on the embodiment, certain operations, acts, events, or functions of any of the algorithms described herein can be performed in a different sequence, can be added, merged, or left out altogether (for example, not all are necessary for the practice of the algorithms). Moreover, in certain embodiments, operations, acts, functions, or events can be performed concurrently, for example, through multi-threaded processing, interrupt processing, or multiple processors or processor cores or on other parallel architectures, rather than sequentially.


Systems and modules described herein can comprise software, firmware, hardware, or any combination(s) of software, firmware, or hardware suitable for the purposes described herein. Software and other modules can reside and execute on servers, workstations, personal computers, computerized tablets, PDAs, and other computing devices suitable for the purposes described herein. Software and other modules can be accessible via local memory, via a network, via a browser, or via other means suitable for the purposes described herein. Data structures described herein can comprise computer files, variables, programming arrays, programming structures, or any electronic information storage schemes or methods, or any combinations thereof, suitable for the purposes described herein. User interface elements described herein can comprise elements from graphical user interfaces, interactive voice response, command line interfaces, and other suitable interfaces.


Further, the processing of the various components of the illustrated systems can be distributed across multiple machines, networks, and other computing resources. In addition, two or more components of a system can be combined into fewer components. Various components of the illustrated systems can be implemented in one or more virtual machines, rather than in dedicated computer hardware systems and/or computing devices. Likewise, the data storage devices shown can represent physical and/or logical data storage, including, for example, storage area networks or other distributed storage systems. Moreover, the connections between the components shown can represent possible paths of data flow, rather than actual connections between hardware. While some examples of possible connections are shown, any of the subset of the components shown can communicate with any other subset of components in various implementations.


Embodiments are also described above with reference to flow chart illustrations and/or block diagrams of methods, apparatus (systems) and computer program products. Each block of the flow chart illustrations and/or block diagrams, and combinations of blocks in the flow chart illustrations and/or block diagrams, can be implemented by computer program instructions. Such instructions can be provided to a processor of a general purpose computer, special purpose computer, specially-equipped computer (for example, comprising a high-performance database server, a graphics subsystem, etc.) or other programmable data processing apparatus to produce a machine, such that the instructions, which execute via the processor(s) of the computer or other programmable data processing apparatus, create means for implementing the acts specified in the flow chart and/or block diagram block or blocks.


These computer program instructions can also be stored in a non-transitory computer-readable memory that can direct a computer or other programmable data processing apparatus to operate in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including instruction means which implement the acts specified in the flow chart and/or block diagram block or blocks. The computer program instructions can also be loaded onto a computing device or other programmable data processing apparatus to cause a series of operations to be performed on the computing device or other programmable apparatus to produce a computer implemented process such that the instructions which execute on the computer or other programmable apparatus provide steps for implementing the acts specified in the flow chart and/or block diagram block or blocks.


Any patents and applications and other references noted above, including any that can be listed in accompanying filing papers, are incorporated herein by reference. Aspects of the disclosure can be modified, if necessary, to employ the systems, functions, and concepts of the various references described above to provide yet further implementations of the disclosure.


These and other changes can be made in light of the above detailed description. While the above description describes certain examples of the disclosure, and describes the best mode contemplated, no matter how detailed the above appears in text, the disclosure can be practiced in many ways. Details of the system can vary considerably in its specific implementation, while still being encompassed by the disclosure disclosed herein. As noted above, particular terminology used when describing certain features or aspects of the disclosure should not be taken to imply that the terminology is being redefined herein to be restricted to any specific characteristics, features, or aspects of the disclosure with which that terminology is associated. In general, the terms used in the following claims should not be construed to limit the disclosure to the specific examples disclosed in the specification, unless the above detailed description section explicitly defines such terms. Accordingly, the actual scope of the disclosure encompasses not only the disclosed examples, but also all equivalent ways of practicing or implementing the disclosure under the claims.

Claims
  • 1. A method, comprising: communicating, to an intercept device, a first set of medication data fields, the first set of medication data fields configured to store a corresponding first set of medication data field values for a particular medication, wherein the particular medication is included in a medicinal container associated with a first identifier corresponding to a computer-readable code, wherein the first identifier uniquely identifies the medicinal container from other medicinal containers that include the particular medication and a same amount of the particular medication as the medicinal container,wherein the intercept device is configured to query, based at least in part on the first identifier, a remotely located database for the first set of medication data field values for the particular medication, wherein the remotely located database stores a second set of medication data fields associated with the medicinal container and a corresponding second set of medication data field values, wherein the first set of medication data field values is a subset of the second set of medication data field values;receiving, from the intercept device, the first set of medication data field values for the particular medication; andstoring the first set of medication data field values in the first set of medication data fields.
  • 2. The method of claim 1, wherein to query the remotely located database the intercept device is configured to transmit the first identifier to a remotely-located tracking system.
  • 3. The method of claim 2, wherein the remotely-located tracking system is configured to: identify the first set of medication data field values for the particular medication based at least in part on the first identifier, and communicate the first set of medication data field values.
  • 4. The method of claim 2, wherein the remotely-located tracking system is configured to update location information associated with the particular medication.
  • 5. The method of claim 1, wherein the first set of medication data field values comprise an NDC number.
  • 6. The method of claim 1, wherein the first set of medication data field values comprise a name of the particular medication.
  • 7. The method of claim 1, wherein the first set of medication data field values comprise recall information.
  • 8. The method of claim 1, wherein the first set of medication data field values comprise at least one of a use-by date or an expiration date.
  • 9. The method of claim 1, further comprising: receiving, from the intercept device, the first identifier; andcommunicating the first set of medication data fields based on the first identifier.
  • 10. The method of claim 1, wherein the first identifier is generated from a scanning device.
  • 11. The method of claim 10, wherein the scanning device comprises an RFID reader.
  • 12. The method of claim 10, wherein the scanning device comprises a barcode scanner.
  • 13. The method of claim 10, wherein the computer-readable code is a one-dimensional barcode or a two-dimensional barcode.
  • 14. A system comprising: a patient information system communicatively coupled with an intercept device, the patient information system comprising a processor configured to:communicate, to an intercept device, a first set of medication data fields, the first set of medication data fields configured to store a corresponding first set of medication data field values for a particular medication, wherein the particular medication is included in a medicinal container associated with a first identifier corresponding to a computer-readable code wherein the first identifier uniquely identifies the medicinal container from other medicinal containers that include the particular medication and a same amount of the particular medication as the medicinal container,wherein the intercept device is configured to query, based at least in part on the first identifier, a remotely located database for the one or more first set of medication data field values for the particular medication, wherein the remotely located database stores a second set of medication data fields associated with the medicinal container and a corresponding second set of medication data field values, wherein the first set of medication data field values is a subset of the second set of medication data field values;receive, from the intercept device, the first set of medication data field values for the particular medication; andstoring the first set of medication data field values in the first set of medication data fields.
  • 15. The system of claim 14, wherein the first set of medication data field values comprise at least one of an NDC number, a name of the particular medication, recall information, a use-by date, or an expiration date.
  • 16. The system of claim 14, wherein the processor is further configured to: receive, from the intercept device, the first identifier; andcommunicate the first set of medication data fields based on the first identifier.
  • 17. The system of claim 14, wherein the first identifier is generated from a scanning device.
  • 18. The system of claim 17, wherein the scanning device comprises at least one of an RFID reader or a barcode scanner.
  • 19. The system of claim 14, wherein to query the remotely located database the intercept device transmits the first identifier to a remotely-located tracking system, and wherein the remotely-located tracking system is configured to: identify the first set of medication data field values for the particular medication based at least in part on the first identifier, andcommunicate the first set of medication data field values.
  • 20. The system of claim 14, further comprising a second identifier remote from the first identifier and comprising information associated with a particular patient, wherein the intercept device is further configured to correlate the first identifier and the second identifier to verify patient administration.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 16/985,594, entitled “SELECTIVE DISTRIBUTION OF PHARMACY ITEM DATA FROM PHARMACY ITEM TRACKING SYSTEM,” filed on Aug. 5, 2020, which claims priority benefit to U.S. Provisional Application No. 62/883,351, entitled “SELECTIVE DISTRIBUTION OF PHARMACY ITEM DATA FROM PHARMACY ITEM TRACKING SYSTEM,” filed Aug. 6, 2019, each of which is hereby incorporated herein by reference in its entirety. Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are incorporated by reference under 37 CFR 1.57 and made a part of this specification.

US Referenced Citations (418)
Number Name Date Kind
4884827 Kelley Dec 1989 A
4961533 Teller et al. Oct 1990 A
5713485 Liff et al. Feb 1998 A
5930145 Yuyama et al. Jul 1999 A
5963134 Bowers et al. Oct 1999 A
5986662 Argiro et al. Nov 1999 A
6112502 Frederick et al. Sep 2000 A
6249299 Tainer Jun 2001 B1
6275157 Mays et al. Aug 2001 B1
6294999 Yarin et al. Sep 2001 B1
6330351 Yasunaga Dec 2001 B1
6574166 Niemiec Jun 2003 B2
6632619 Harrison et al. Oct 2003 B1
6771369 Rzasa et al. Aug 2004 B2
6825864 Botten et al. Nov 2004 B2
6842736 Brzozowski Jan 2005 B1
6847861 Lunak et al. Jan 2005 B2
6851615 Jones Feb 2005 B2
6861954 Levin Mar 2005 B2
6877658 Raistrick et al. Apr 2005 B2
6879876 O'Dougherty et al. Apr 2005 B2
6900021 Harrison et al. May 2005 B1
6933849 Sawyer Aug 2005 B2
6935560 Andreasson et al. Aug 2005 B2
6952681 McQuade et al. Oct 2005 B2
6985870 Martucci et al. Jan 2006 B2
6992574 Aupperle et al. Jan 2006 B2
6994249 Peterka et al. Feb 2006 B2
7036729 Chung May 2006 B2
7061831 De La Huerga Jun 2006 B2
7111780 Broussard et al. Sep 2006 B2
7116343 Botten et al. Oct 2006 B2
7118029 Nycz et al. Oct 2006 B2
7140542 Andreasson et al. Nov 2006 B2
7146247 Kirsch et al. Dec 2006 B2
7151456 Godfrey Dec 2006 B2
7158030 Chung Jan 2007 B2
7165077 Kalies Jan 2007 B2
7175081 Andreasson et al. Feb 2007 B2
7177721 Kirsch et al. Feb 2007 B2
7178729 Shaffer et al. Feb 2007 B2
7182256 Andreasson et al. Feb 2007 B2
7212100 Terenna May 2007 B2
7212127 Jacober et al. May 2007 B2
7227469 Varner et al. Jun 2007 B2
7232066 Andreasson et al. Jun 2007 B2
7253736 Tethrake et al. Aug 2007 B2
7256699 Tethrake et al. Aug 2007 B2
7263501 Tirinato et al. Aug 2007 B2
7264323 Tainer et al. Sep 2007 B2
7268684 Tethrake et al. Sep 2007 B2
7275645 Mallett et al. Oct 2007 B2
7299981 Hickle et al. Nov 2007 B2
7316231 Hickle Jan 2008 B2
7317393 Maloney Jan 2008 B2
7318529 Mallett et al. Jan 2008 B2
7339550 Hayama et al. Mar 2008 B2
7341147 Mallett et al. Mar 2008 B2
7348884 Higham Mar 2008 B2
7354884 Hada et al. Apr 2008 B2
7362228 Nycz et al. Apr 2008 B2
7375737 Botten et al. May 2008 B2
7394383 Hager et al. Jul 2008 B2
7440818 Handfield et al. Oct 2008 B2
7446747 Youngblood et al. Nov 2008 B2
7454880 Austin et al. Nov 2008 B1
7486188 Van Alstyne Feb 2009 B2
7492257 Tethrake et al. Feb 2009 B2
7492261 Cambre et al. Feb 2009 B2
7504954 Spaeder Mar 2009 B2
7518502 Austin et al. Apr 2009 B2
7518516 Azevedo et al. Apr 2009 B2
7551089 Sawyer Jun 2009 B2
7559483 Hickle et al. Jul 2009 B2
7564364 Zweig Jul 2009 B2
7630791 Nguyen et al. Dec 2009 B2
7639136 Wass et al. Dec 2009 B1
7644016 Nycz et al. Jan 2010 B2
7672872 Shanton Mar 2010 B2
7706915 Mohapatra et al. Apr 2010 B2
7706916 Hilton Apr 2010 B2
7712670 Sauerwein, Jr. et al. May 2010 B2
7715277 De La Huerga May 2010 B2
7729597 Wright et al. Jun 2010 B2
7734157 Wright et al. Jun 2010 B2
7737858 Matityaho Jun 2010 B2
7747477 Louie et al. Jun 2010 B1
7752085 Monroe Jul 2010 B2
7772964 Tethrake et al. Aug 2010 B2
7775056 Lowenstein Aug 2010 B2
7783163 Wright et al. Aug 2010 B2
7783174 Wright et al. Aug 2010 B2
7801422 Wright et al. Sep 2010 B2
7815117 Tuschel et al. Oct 2010 B2
7834765 Sawyer Nov 2010 B2
7834766 Sawyer Nov 2010 B2
7837093 Leu et al. Nov 2010 B1
7837107 Leu et al. Nov 2010 B1
7858841 Krautkramer et al. Dec 2010 B2
7860730 Goodall et al. Dec 2010 B1
7868754 Salvat, Jr. Jan 2011 B2
7893876 Brown et al. Feb 2011 B2
7908030 Handfield et al. Mar 2011 B2
7918830 Langan et al. Apr 2011 B2
7928844 Mackenzie et al. Apr 2011 B2
7933033 Ohishi et al. Apr 2011 B2
7976508 Hoag Jul 2011 B2
7985711 Tohmatsu et al. Jul 2011 B2
7990272 Wass et al. Aug 2011 B2
7996286 Kreiner et al. Aug 2011 B2
8002174 Coyne, III et al. Aug 2011 B2
8006903 Braun et al. Aug 2011 B2
8009913 Greyshock Aug 2011 B2
8019471 Bogash Sep 2011 B2
8031347 Edwards et al. Oct 2011 B2
8042738 Cloix Oct 2011 B2
8049627 Addante Nov 2011 B1
8063925 Tainer et al. Nov 2011 B2
8065858 Leu et al. Nov 2011 B2
8072635 Roberts et al. Dec 2011 B2
8077041 Stern et al. Dec 2011 B2
8082192 Nycz et al. Dec 2011 B2
8099339 Pinsonneault et al. Jan 2012 B1
8108068 Boucher et al. Jan 2012 B1
8111159 Andreasson et al. Feb 2012 B2
8112175 Handfield et al. Feb 2012 B2
8131397 Vahlberg et al. Mar 2012 B2
8154390 Heath et al. Apr 2012 B2
8174392 Sagbhini et al. May 2012 B1
8186587 Zmood et al. May 2012 B2
8212677 Ferguson Jul 2012 B2
8219413 Martinez et al. Jul 2012 B2
8224483 Ansari et al. Jul 2012 B1
8231749 Dent et al. Jul 2012 B2
8258961 Phillips et al. Sep 2012 B2
8261939 Knoth Sep 2012 B2
8271128 Schultz Sep 2012 B1
8279069 Sawyer Oct 2012 B2
8283287 Aihara et al. Oct 2012 B2
8284059 Ross Oct 2012 B2
8285083 Canessa et al. Oct 2012 B2
8285607 Danilewitz Oct 2012 B2
8286222 Silverbrook et al. Oct 2012 B2
8292173 Yturralde et al. Oct 2012 B2
8292186 Deloche et al. Oct 2012 B2
8296950 Colbrunn et al. Oct 2012 B2
8313024 Marino Nov 2012 B2
8319607 Grimlund et al. Nov 2012 B2
8328082 Bochenko et al. Dec 2012 B1
8339649 Ohishi et al. Dec 2012 B2
8341041 Hull Dec 2012 B2
8346632 Saghbini Jan 2013 B2
8355753 Bochenko et al. Jan 2013 B2
8355962 Delaney et al. Jan 2013 B2
8359338 Butterfield et al. Jan 2013 B2
8371448 Reaux Feb 2013 B1
8376228 DeVet et al. Feb 2013 B2
8384545 Hussain et al. Feb 2013 B2
8385972 Bochenko et al. Feb 2013 B2
8386070 Eliuk et al. Feb 2013 B2
8394053 Bochenko et al. Mar 2013 B2
8403212 van Esch Mar 2013 B2
8403224 Fedorko et al. Mar 2013 B2
8405508 Burke Mar 2013 B2
8438067 Omura et al. May 2013 B2
8461076 Okada et al. Jun 2013 B2
8483550 Wright et al. Jul 2013 B2
8509604 Wright et al. Aug 2013 B2
8515251 Wright et al. Aug 2013 B2
8519849 Ross-Messemer Aug 2013 B2
8530379 Shimizu et al. Sep 2013 B2
8564416 Steven et al. Oct 2013 B2
8565552 Sommer et al. Oct 2013 B2
8582171 Srnka et al. Nov 2013 B2
8589271 Evans Nov 2013 B2
8593278 Churbock et al. Nov 2013 B2
8593678 Ohishi et al. Nov 2013 B2
D694817 Adam et al. Dec 2013 S
8600548 Bossi Dec 2013 B2
8606596 Bochenko et al. Dec 2013 B1
8636202 Keefe et al. Jan 2014 B2
8639525 Levine et al. Jan 2014 B2
8686859 Hussain et al. Apr 2014 B2
8699054 Edwards et al. Apr 2014 B2
8702674 Bochenko Apr 2014 B2
8723674 Conley et al. May 2014 B2
8749356 Hussain et al. Jun 2014 B2
8755056 Edwards et al. Jun 2014 B2
8825680 Burke et al. Sep 2014 B2
8838215 John et al. Sep 2014 B2
8868616 Otto et al. Oct 2014 B1
8893970 Keefe et al. Nov 2014 B2
8922435 Fontecchio et al. Dec 2014 B2
8935280 Bauman et al. Jan 2015 B2
8945066 Bochenko et al. Feb 2015 B2
8948478 Keefe et al. Feb 2015 B2
8985388 Ratnakar Mar 2015 B2
8990099 MacDonald et al. Mar 2015 B2
9037479 MacDonald et al. May 2015 B1
9058412 MacDonald et al. Jun 2015 B2
9058413 MacDonald et al. Jun 2015 B2
9058435 Keefe et al. Jun 2015 B2
9171280 Gitchell et al. Oct 2015 B2
9189769 Caputo et al. Nov 2015 B2
9367665 MacDonald et al. Jun 2016 B2
9449296 MacDonald et al. Sep 2016 B2
9539374 Halpern Jan 2017 B2
9582644 Gitchell et al. Feb 2017 B2
9734294 MacDonald et al. Aug 2017 B2
9805169 MacDonald et al. Oct 2017 B2
10083766 Gitchell et al. Sep 2018 B2
10210954 Caputo et al. Feb 2019 B2
10600513 Gitchell et al. Mar 2020 B2
10609845 Elizondo, II Mar 2020 B2
9058413 MacDonald et al. Apr 2020 C1
10621394 Hussain et al. Apr 2020 B2
10643743 Caputo et al. May 2020 B2
10658077 Hussain et al. May 2020 B2
10658078 Caputo et al. May 2020 B2
10664740 Elizondo, II May 2020 B2
10853380 Agnew et al. Dec 2020 B1
10930393 Gitchell et al. Feb 2021 B2
11017352 MacDonald et al. May 2021 B2
11037342 Agnew et al. Jun 2021 B1
11139075 MacDonald et al. Oct 2021 B2
11551797 Kress-Spatz Jan 2023 B2
20020026330 Klein Feb 2002 A1
20020049650 Reff Apr 2002 A1
20020087360 Pettit Jul 2002 A1
20020087362 Cobb et al. Jul 2002 A1
20020087554 Seelinger Jul 2002 A1
20030055685 Cobb et al. Mar 2003 A1
20030074223 Hickle et al. Apr 2003 A1
20030102970 Creel et al. Jun 2003 A1
20030160698 Andreasson et al. Aug 2003 A1
20030216974 Browne Nov 2003 A1
20040008123 Carrender et al. Jan 2004 A1
20040032330 Hoffman Feb 2004 A1
20040051368 Caputo et al. Mar 2004 A1
20040057609 Weinberg Mar 2004 A1
20040081669 Greeven et al. Apr 2004 A1
20040158507 Meek et al. Aug 2004 A1
20040178071 Harrison et al. Sep 2004 A1
20040215486 Braverman Oct 2004 A1
20040225528 Brock Nov 2004 A1
20050014849 Pettit et al. Jan 2005 A1
20050060171 Molnar Mar 2005 A1
20050062603 Fuerst et al. Mar 2005 A1
20050108044 Koster May 2005 A1
20050125097 Chudy et al. Jun 2005 A1
20050127176 Dickinson Jun 2005 A1
20050149378 Cyr et al. Jul 2005 A1
20050149414 Schrodt et al. Jul 2005 A1
20050184151 DiMaggio et al. Aug 2005 A1
20050283259 Wolpow Dec 2005 A1
20050285732 Sengupta et al. Dec 2005 A1
20050285746 Sengupta et al. Dec 2005 A1
20060006999 Walczyk et al. Jan 2006 A1
20060043177 Nycz et al. Mar 2006 A1
20060043179 Nycz et al. Mar 2006 A1
20060065726 Andreasson et al. Mar 2006 A1
20060109105 Varner et al. May 2006 A1
20060132311 Kruest et al. Jun 2006 A1
20060145871 Donati et al. Jul 2006 A1
20060152338 Hsu Jul 2006 A1
20060152364 Walton Jul 2006 A1
20060152367 Narayanaswamy Jul 2006 A1
20060208886 Beamer Sep 2006 A1
20060244593 Nycz et al. Nov 2006 A1
20060267731 Chen Nov 2006 A1
20070001809 Kodukula et al. Jan 2007 A1
20070008399 Botten et al. Jan 2007 A1
20070023512 Miller et al. Feb 2007 A1
20070023513 Andreasson et al. Feb 2007 A1
20070074722 Giroux et al. Apr 2007 A1
20070114279 Lessing et al. May 2007 A1
20070185615 Bossi Aug 2007 A1
20070187475 MacLeod Aug 2007 A1
20070188306 Tethrake et al. Aug 2007 A1
20070200702 Chung Aug 2007 A1
20070213659 Trovato et al. Sep 2007 A1
20070213684 Hickle et al. Sep 2007 A1
20070229268 Swan et al. Oct 2007 A1
20070272746 Ortiz et al. Nov 2007 A1
20080004908 Oh et al. Jan 2008 A1
20080012687 Rubinstein Jan 2008 A1
20080045930 Makin et al. Feb 2008 A1
20080046295 Albrecht Feb 2008 A1
20080061153 Hickle et al. Mar 2008 A1
20080094214 Azevedo et al. Apr 2008 A1
20080122878 Keefe et al. May 2008 A1
20080128482 Chen et al. Jun 2008 A1
20080129496 Koblasz Jun 2008 A1
20080150722 Jackson Jun 2008 A1
20080157967 Jones et al. Jul 2008 A1
20080172253 Chung et al. Jul 2008 A1
20080186180 Butler et al. Aug 2008 A1
20080191013 Liberatore Aug 2008 A1
20080218307 Schoettle Sep 2008 A1
20080228160 Harrison Sep 2008 A1
20080231456 Matityaho Sep 2008 A1
20080243088 Evans Oct 2008 A1
20080270178 McRae et al. Oct 2008 A1
20080296373 Smood et al. Dec 2008 A1
20080297356 Oberle Dec 2008 A1
20080306772 Shahrokh Dec 2008 A1
20080316045 Sriharto et al. Dec 2008 A1
20090002173 Bergsten et al. Jan 2009 A1
20090020442 Dietrich et al. Jan 2009 A1
20090058653 Geissler et al. Mar 2009 A1
20090144087 Kelsch et al. Jun 2009 A1
20090153290 Bierach Jun 2009 A1
20090164042 Handfield et al. Jun 2009 A1
20090194987 Christie et al. Aug 2009 A1
20090224891 Vishik et al. Sep 2009 A1
20090231138 Cheung et al. Sep 2009 A1
20090267740 Pizzuto et al. Oct 2009 A1
20090267772 Dehnadi Oct 2009 A1
20090277815 Kohl Nov 2009 A1
20090294521 De La Huerga Dec 2009 A1
20100022953 Bochenko et al. Jan 2010 A1
20100022987 Bochenko Jan 2010 A1
20100036310 Hillman Feb 2010 A1
20100036678 Bray Feb 2010 A1
20100036755 Saghbini Feb 2010 A1
20100042439 Martinez et al. Feb 2010 A1
20100079337 Hsu et al. Apr 2010 A1
20100098425 Kewitsch Apr 2010 A1
20100108761 Nycz et al. May 2010 A1
20100185458 Calderwood et al. Jul 2010 A1
20100204659 Bochenko Aug 2010 A1
20100217621 Schoenberg et al. Aug 2010 A1
20100219097 Ramasubramanian et al. Sep 2010 A1
20100238039 Tethrake et al. Sep 2010 A1
20100268548 Garrett et al. Oct 2010 A1
20100275625 Lowenstein Nov 2010 A1
20100299158 Siegel Nov 2010 A1
20100328474 Hsieh Dec 2010 A1
20100332246 Fedorko et al. Dec 2010 A1
20110006879 Bartos Jan 2011 A1
20110060455 Bogash Mar 2011 A1
20110063091 Kang Mar 2011 A1
20110068922 Ross Mar 2011 A1
20110112682 Matsukawa et al. May 2011 A1
20110115612 Kulinets et al. May 2011 A1
20110125315 Handfield et al. May 2011 A1
20110131056 Chudy et al. Jun 2011 A1
20110139871 Yturralde et al. Jun 2011 A1
20110161112 Keefe et al. Jun 2011 A1
20110163871 Einav et al. Jul 2011 A1
20110166878 Louie et al. Jul 2011 A1
20110184751 Holmes Jul 2011 A1
20110187549 Balasing Aug 2011 A1
20110202174 Bogash Aug 2011 A1
20110225100 Sangal et al. Sep 2011 A1
20110227722 Salvat, Jr. Sep 2011 A1
20110240729 Schuck Oct 2011 A1
20110257991 Shukla Oct 2011 A1
20110270441 Handfield et al. Nov 2011 A1
20110291809 Niemiec et al. Dec 2011 A1
20110301446 Kamen Dec 2011 A1
20110313395 Krulevitch et al. Dec 2011 A1
20120037266 Bochenko Feb 2012 A1
20120041778 Kraft Feb 2012 A1
20120044054 Hussain et al. Feb 2012 A1
20120061463 Burke Mar 2012 A1
20120089411 Srnka et al. Apr 2012 A1
20120089418 Kamath et al. Apr 2012 A1
20120116798 Heath et al. May 2012 A1
20120125994 Heath et al. May 2012 A1
20120130534 Wurm May 2012 A1
20120173440 Becker et al. Jul 2012 A1
20120179132 Valk et al. Jul 2012 A1
20120185951 Bauman et al. Jul 2012 A1
20120209619 Knotts et al. Aug 2012 A1
20120240067 Bauman et al. Sep 2012 A1
20120273087 Einy et al. Nov 2012 A1
20120278096 Holness Nov 2012 A1
20120278228 Rubinstein Nov 2012 A1
20120323208 Bochenko et al. Dec 2012 A1
20120325330 Prince et al. Dec 2012 A1
20130018356 Prince et al. Jan 2013 A1
20130038452 Sawyer Feb 2013 A1
20130041784 Danilewitz Feb 2013 A1
20130092727 Edwards et al. Apr 2013 A1
20130105568 Jablonski et al. May 2013 A1
20130151005 Gerold et al. Jun 2013 A1
20130191149 Kolberg et al. Jul 2013 A1
20130197927 Vanderveen et al. Aug 2013 A1
20130218329 Henderson et al. Aug 2013 A1
20130221082 Botten Aug 2013 A1
20130225945 Prince et al. Aug 2013 A1
20140060729 Srnka et al. Mar 2014 A1
20140066880 Prince et al. Mar 2014 A1
20140114472 Bossi Apr 2014 A1
20140117081 Jablonski et al. May 2014 A1
20140136229 Levine et al. May 2014 A1
20140142975 Keefe et al. May 2014 A1
20140184390 Elizondo, II Jul 2014 A1
20140184391 Elizondo, II Jul 2014 A1
20140197954 Caputo et al. Jul 2014 A1
20140210596 Hussain et al. Jul 2014 A1
20140262919 Hussain et al. Sep 2014 A1
20140263614 Keefe et al. Sep 2014 A1
20140276213 Bochenko Sep 2014 A1
20140282197 Keefe et al. Sep 2014 A1
20140291397 Caputo et al. Oct 2014 A1
20140367080 Hussain et al. Dec 2014 A1
20150058182 Kress-Spatz et al. Feb 2015 A1
20170109497 Tribble et al. Apr 2017 A1
20180247703 D'Amato Aug 2018 A1
20190088354 Yanowitz et al. Mar 2019 A1
20190272396 Clouser et al. Sep 2019 A1
20190304583 Henderson et al. Oct 2019 A1
20200013494 Caputo et al. Jan 2020 A1
20200167534 Elizondo, II May 2020 A1
20210319872 Valentine Oct 2021 A1
20220282199 Vann Sep 2022 A1
Foreign Referenced Citations (19)
Number Date Country
2 722 328 Oct 2009 CA
2 790 220 Jun 2013 CA
102791310 Dec 2014 CN
2 496 283 Sep 2012 EP
201204914 Oct 2013 IN
WO 02095675 Nov 2002 WO
WO 03071943 Sep 2003 WO
WO 2006026246 Mar 2006 WO
WO 2006135830 Dec 2006 WO
WO 2010074781 Jul 2010 WO
WO 2011056888 Sep 2011 WO
WO 2011115676 Sep 2011 WO
WO 2011150013 Dec 2011 WO
WO 2013082423 Jun 2013 WO
WO 2013116873 Aug 2013 WO
WO 2013134256 Sep 2013 WO
WO 2014159928 Oct 2014 WO
WO 2014189834 Nov 2014 WO
WO 2015026387 Feb 2015 WO
Non-Patent Literature Citations (194)
Entry
“AmerisourceBergen Specialty Group Reconfigures Cubixx Medical Cabinet”, Jan. 9, 2011, pp. 2, <https://web.archive.org/web/20180620192642/http://pharmaceuticalcommerce.com/supply-chain-logistics/amerisourcebergen-specialty-group-reconfigures-cubixx-medical-cabinet/>.
Bacheldor, Beth, “ASD Healthcare Deploys RFID Refrigerated Drug Cabinets”, RFID Journal, Sep. 24, 2007, p. 1. <http://www.rfidjournal.com/articles/view?3632>.
Bacheldor, Beth, “Cardinal Health Readies Item-Level Pilot”, RFID Journal, May 31, 2006, p. 1. <http://www.rfidjournal.com/articles/view?2380>.
Bacheldor, Beth, “UCSD Medical Center Expands Its RFID Deployment”, RFID Journal, Oct. 29, 2008, pp. 2. <http://www.rfidjournal.com/articles/view?4423>.
Bacheldor, Beth, “UMass Med Center Finds Big Savings Through Tagging”, RFID Journal, Nov. 21, 2007, pp. 2. <http://www.rfidjournal.com/articles/view?3763/2>.
Barlas, Stephen, “Pharmacy Product Tracing Likely to Go National—Costs to Pharmacies Worrisome,” Pharmacy & Therapeutics, Jan. 2009, vol. 34 No. 1, p. 14.
Baum, “How did RFID help University of MD Medical Center cut medication error rate?” Med City News, https://medcitynews.com/2013/12/rfid-help-university-md-medical-center-cut-medication-error-rate/?rf=1, Dec. 4, 2013, 2 Pages.
Becker et al., “SmartDrawer: RFID-Based Smart Medicine Drawer for Assistive Environments”, Conference: Proceedings of the 2nd International Conference on Pervasive Technologies Related to Assistive Environments, PETRA 2009, Corfu, Greece, Jun. 9-13, 2009, pp. 8.
Belson, D., “Storage, Distribution, and Dispensing of Medical Supplies,” Create Interim Report Under FEMA Grant EMW-2004-GR-0112, Apr. 21, 2005, pp. 1-36.
Bendavid et al., “Using RFID to Improve Hospital Supply Chain Management for High Value and Consignment Items”, Procedia Computer Science, vol. 5, 2011, pp. 849-856.
Bendavid et al., “Redesigning the Replenishment Process of Medical Supplies in Hospitals with RFID”, Business Process Management Journal, 2010, vol. 16, No. 6, pp. 991-1013.
Brown, Dennis E., “RFID Implementation”, McGraw-Hill Communications, 2007, Ch. 3 & 7 (portions), pp. 62-65, 81, 92-96, 106-113, 188-193 & 429.
Bryant, Blake, “Hacking SIEMs to Catch Hackers: Decreasing the Mean Time to Respond to Network Security Events with a Novel Threat Ontology in SIEM Software”, Master's Thesis, University of Kansas, 2016, pp. 257.
Çakici et al., “Using RFID for the Management of Pharmaceutical Inventory—System Optimization and Shrinkage Control,” Decision Support Systems, 2011, pp. 842-852.
Cangialosi et al., “Leveraging RFID in Hospitals: Patient Life Cycle and Mobility Perspectives”, IEEE Applications & Practice, Sep. 2007, pp. 18-23.
Chao et al., “Determining Technology Trends and Forecasts of RFID by a Historical Review and Bibliometric Analysis from 1991 to 2005”, Technovation, vol. 27, 2007, pp. 268-279.
Collins, “RFID Cabinet Manages Medicine”, RFID Journal, Aug. 12, 2004, p. 1. <http://www.rfidjournal.com/articles/pdf?1081>.
CPG Sec. 400.210, Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs Nov. 2004 Compliance Policy Guide available at: <http://www.fda.gov/ICECI/ComplianceManuals/CompliancePolicyGuidanceManual/ucm074357.htm>.
“Crash Cart Inventory Checklist”, Outpatient Surgery Magazine, Oct. 2004, p. 1. <http://www.outpatientsurgery.net/resources/forms/2004/pdf/OutpatientSurgeryMagazine_0410_crashCart.pdf>.
Curtin et al., “Making the ‘Most’ out of RFID: a research agenda for the study of the adoption, usage and impact of RFID,” Information Technology Management, Apr. 2007, pp. 87-110.
“Data Gathering Developments”, Manufacturing Chemist, Feb. 1, 2005, p. 24. <https://www.manufacturingchemist.com/news/article_page/Data_gathering_developments/35805>.
Dutta et al., “RFID and Operations Management: Technology, Value, and Incentives”, Production and Operations Management (POMS), vol. 16, No. 5, Sep.-Oct. 2007, pp. 646-655.
Edwards, John, “RFID Smart Shelves and Cabinets”, RFID Journal, Aug. 24, 2009, pp. 4. <http://www.rfidjournal.com/articles/view?5140/4>.
Electric Power Group v. Alstom, S.A., 830 F.3d 1350, 1353-54, 119 USPQ2d 1739, 1741-42 (Fed. Cir. 2016), pp. 12.
Epstein et al., “Development of a Scheduled Drug Diversion Surveillance System Based on an Analysis of Atypical Drug Transactions”, Anesthesia and Analgesia, Oct. 2007, vol. 105, No. 4, pp. 1053-1060.
Erdem et al., “Investigation of RFID Tag Readability for Pharmaceutical Products at Item Level”, Drug Development and Industrial Pharmacy, 2009, vol. 35, No. 11, pp. 1312-1324.
Fahrni, Jerry, “More RFID Refrigerator Stuff—Cubixx and myCubixx”, Sep. 3, 2012, pp. 4. <http://jerryfahrni.com/2012/09/more-rfid-refrigerator-stuff-cubixx-and-mycubixx/>.
“Faraday Cage”, Wikipedia, last edited Apr. 12, 2018, pp. 5. <https://en.wikipedia.org/wiki/Faraday_cage>.
Floerkemeier et al., “The Smart Box Concept for Ubiquitous Computing Environments”, The Smart Box Concept for Ubiquitous Computing Environments, 2004, pp. 4.
Garza, Anyssa, “The Future of Pharmacy Medication Kit Storage”, Pharmacy Times, https://www.pharmacytimes.com/contributor/anyssa-garza/2014/12/the-future-of-pharmacy-medication-kit-storage, Dec. 12, 2014, 2 Pages.
Glover et al., “RFID Essentials”, O'Reilly Media, 2006, pp. 2, 14, 24, 31, 33, 107-110, 113-114, 117, 137-143, 162-169, 178-179.
Gonzalez, Stephanie, “Health Maintenance System (HMS) Hardware Research, Design, and Collaboration,” NASA USRP—Internship Final Report, 2010, pp. 1-20.
Green, Kathryn, “Doing the Wave: Inventory Management with RFID”, Diagnostic & Interventional Services, UMass Memorial Medical Center, Worcester, MA, vol. 15, No. 9, Sep. 2007, pp. 7. <https://www.cathlabdigest.com/articles/Doing-Wave-Inventory-Management-RFID>.
Harrop et al., “RFID for Healthcare and Pharmaceuticals, 2008-2018,” Securing Pharma, May 2008, pp. 1-12.
Hawkins-Simons, “RFID Streamlines Refilling of Drug Trays”, Pharmacy Technology Report, https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-14/RFID-Streamlines-Refilling-of-Drug-Trays/26159, Mar. 21, 2014, 9 Pages.
Ho et al., “A Prototype on RFID and Sensor Networks for Elder Healthcare: Progress Report”, SIGCOMM '05 Workshops, Aug. 22-26, 2005, Philadelphia, PA, pp. 70-75.
Houliston, Bryan, “Integrating RFID Technology into a Drug Administration System,” Bulletin of Applied Computing and Information Technology, vol. 3, No. 1, May 2005, pp. 8. Retrieved Sep. 26, 2013 from <http://citrenz.ac.nz/bacit/0301/2005Houliston_RFID.htm>.
Howard, JD, “Implementation of RFID in the Pharmaceutical Industry”, Advisor: Dr. Jay Singh, California Polytechnic State University, San Luis Obispo, CA, Feb. 2009, pp. 11.
Humble, RN, Carol, “How RFID Freed Nurses From the Pain of Inventory Duties”, Cath Lab Digest, Dec. 2009, vol. 17, No. 12. <https://www.cathlabdigest.com/articles/How-RFID-Freed-Nurses-From-Pain-Inventory-Duties>.
“Intel & Siemens Launch RFID Blood Bank in Malaysia”, RFID Journal, Aug. 16, 2007, p. 1. <https://www.rfidjournal.com/articles/view?6801>.
Jones et al., “The Benefits, Challenges and Impacts of Radio Frequency Identification Technology (RFID) for Retailers in the UK”, Marketing Intelligence & Planning, Mar. 2005, vol. 23, No. 4, pp. 395-402.
Jorgensen et al., “Executable Use Cases: Requirements for a Pervasive Health Care System,” IEEE Software, Mar./Apr. 2004, pp. 34-41.
Juels, Ari, “RFID Security and Privacy: A Research Survey”, IEEE Journal on Selected Areas in Communications, vol. 24, No. 2, Feb. 2006, pp. 381-394.
Kinsella, Bret, “Premier, Inc. Identifies Kit Check as ‘Technology Breakthrough Product’—Awards exclusive agreement for pharmacy kit medication tracking solution”, Press Release, https://kitcheck.com/2014/04/premier-inc-identifies-kit-check-technology-breakthrough-product-awards-exclusive-agreement-pharmacy-kit-medication-tracking-solution/, Apr. 2, 2014, 5 Pages.
KitCheck, Bluesight for Controlled Substances Overview, as retrieved Aug. 30, 2018 from https://web.archive.org/web/20180830001131/https://kitcheck.com/learn-more/video/bluesight-for-controlled-substances-overview/ in 1 page.
KitCheck, Diversion Events, as retrieved Aug. 30, 2018 from https://web.archive.org/web/20180830001851/https://kitcheck.com/solutions/controlled-substances/diversion-events/ in 3 pages.
KitCheck, “PharMEDium Prefilled Syringes with Kit Check: ASHP Symposium Summary”, Jun. 2016, <https://kitcheck.com/wp-content/uploads/2016/06/pharmedium-prefilled-syringes-with-kit-check-download.pdf> in 9 pages.
KitCheck, Security, as retrieved Aug. 30, 2018 from https://web.archive.org/web/20180830000040/https://kitcheck.com/security/ in 1 page.
KitCheck, “St. Rita's Medical Center: 75% First-year ROI, Less Frustration”, Case Study, 2016, <https://kitcheck.com/learn-more/case-study/st-ritas-medical-center/> in 2 pages.
Lahtela et al., “RFID and NFC in Healthcare: Safety of Hospitals Medication Care”, 2008 Second International Conference on Pervasive Computing Technologies for Healthcare, Tampere, Finland, Jan. 30-Feb. 1, 2008, pp. 4.
Lai et al., “Enhancing Medication Safety and Reduce Adverse Drug Events on Inpatient Medication Administration using RFID,” WSEAS Transactions on Communications, Oct. 2008, vol. 7, No. 10, pp. 1045-1054.
Lampe et al., “The Smart Box Application Model,” Advances in Pervasive Computing, 2004, pp. 1-6.
Lewis, Mark O., “RFID-Enabled Capabilities and their Impact on Healthcare Process Performance”, 31st International Conference on Information Systems, St. Louis, 2010, pp. 1-20.
Liu et al., “Point-of-Care Support for Error-Free Medication Process” (Jun. 25, 2007), retrieved Aug. 21, 2017, 12 pages, available at http://ieeexplore.ieee.org/document/4438162/.
McCall et al., “RMAIS: RFID-based Medication Adherence Intelligence System” (Aug. 31, 2010), retrieved Aug. 21, 2017, 4 pages, available at http://ieeexplore.ieee.org/document/5627529/.
“McKesson's Announces New Touch-Screen Driven Medication Dispensing Solution”, Business Wire, Jun. 15, 2009, pp. 2, Available at: <http://www.businesswire.com/news/home/20090615005349/en/McKesson-Announces-Touch-Screen-Driven-Medication-Dispensing-Solution#.VR7quPnF_10>.
“Medical Packaging Inc. Announces Clear Stem Flag Label System for Ampoules, Vials, and Syringes” Feb. 1, 2006 available at: <http://www.medpak.com/v1/news/20060201_CSFLAG.pdf>, in 1 page.
“Medication Tray Management” Pharmacy Purchasing & Products, Feb. 2018, pp. 18 & 20.
“Medication Tray Management” Pharmacy Purchasing & Products, Presentation, Nov. 2018, pp. 76 & 78.
“Medication Tray Management” Pharmacy Purchasing & Products, State of Pharmacy Automation, Aug. 2016, pp. 42 & 45.
“Medication Tray Management” Pharmacy Purchasing & Products, State of Pharmacy Automation, Aug. 2019, pp. 34-35.
Mehrjerdi, Yahia Zare, “RFID-Enabled Healthcare Systems: Risk-Benefit Analysis”, International Journal of Pharmaceutical and Healthcare Marketing, 2010, vol. 4, No. 3, pp. 282-300.
Meiller et al., “Adaptive Knowledge-Based System for Health Care Applications with RFID-Generated Information”, Decision Support Systems, vol. 51, 2011, pp. 198-207.
Mowry, Mike, “A Survey of RFID in the Medical Industry: With Emphasis on Applications to Surgery and Surgical Devices”, MAE188, Introduction to RFID, Dr. Rajit Gadh, UCLA, Jun. 9, 2008, pp. 22.
“New RFID Medical Cabinets Deployed at 50 Hospitals”, RFID Journal, Sep. 17, 2007, pp. 2. <https://www.rfidjournal.com/articles/view?6823>.
New et al., “Utilize ADC Transaction Data to Detect Diversion”, Oct. 2017, vol. 14, No. 10, pp. 3, as retrieved from https://www.pppmag.com/article/2119/.
O'Connor, Mary Catherine, “Drug Distributor Uses RFID to Vend Meds”, RFID Journal, May 23, 2006, pp. 2. <https://www.rfidjournal.com/articles/view?2363/2>.
O'Connor, Mary Catherine, “GlaxoSmithKline Tests RFID on HIV Drug”, RFID Journal, Mar. 24, 2006, pp. 2. <https://www.rfidjournal.com/articles/view?2219/>.
O'Connor, Mary Catherine, “Interrogators Start to Evolve”, RFID Journal, Jun. 1, 2006, pp. 3. <http://www.rfidjournal.com/purchase-access?type=Article&id=2398&r=%2Farticles%2Fview%3F2398>.
O'Connor, Mary Catherine, “Johnson & Johnson Finds Value in Multiple RFID Apps”, RFID Journal, Apr. 23, 2008, pp. 2. <http://www.rfidjournal.com/articles/pdf?4046>.
O'Connor, Mary Catherine, “McKesson Starts RFID Pilot for Viagra”, RFID Journal, Feb. 17, 2005, pp. 2. <http://www.rfidjournal.com/articles/view?2157>.
O'Connor, Mary Catherine, “Pfizer Using RFID to Fight Fake Viagra”, RFID Journal, Jun. 6, 2006, pp. 2. <http://www.rfidjournal.com/articles/pdf?2075>.
O'Connor, Mary Catherine, “To Keep Drugs from Expiring, Hospital Tests Intelliguard System”, RFID Journal, Jan. 12, 2011, pp. 3. <http://www.rfidjournal.com/articles/view?8123>.
“Odin Innovation Lab: EasyTunnel RFID”, as posted Jul. 13, 2009, archived via archive.org <https://web.archive.org/web/20200316173502/https://www.youtube.com/watch?v=0rQhT4slQnw>, 1 page.
“Odin RFID HQ Tour 2009”, as posted Mar. 19, 2009, archived via archive.org <https://web.archive.org/web/20200316180429/https://www.youtube.com/watch?v=4Y4XIID0B_Y>, 1 page.
O'Driscoll et al, “RFID: An Ideal Technology for Ubiquitous Computing?” Dublin Institute of Technology School of Electronic and Communications Conference Papers, Jan. 1, 2008, pp. 1-17.
Pace et al., “Distributed Ambulatory Research in Therapeutics Network (DARTNet): Summary Report”, Effective Health Care Research Reports, No. 14, Agency for Healthcare Research and Quality, Jul. 2009, pp. 41.
Pappu, Ph.D et al., “RFID in Hospitals: Issues and Solutions” Consortium for the Accelerated Deployment of RFID in Distribution, Sep. 2004, pp. 1-12.
Parida et al., “Application of RFID Technology for In-House Drug Management System”, 15th International Conference on Network-Based Information Systems, 2012, pp. 577-581.
“RFID Medical Cabinets Evaluated in New Benchmark”, RFID Journal, Sep. 12, 2007, pp. 2. <http://www.rfidjournal.com/articles/view?6819>.
Roberti, Mark, “RFID Basics for Health Care”, RFID in Health Care, Produced by RFID Journal, Sep. 17, 2009, The Westin Waltham-Boston, Waltham, MA, pp. 33.
Saygin, C., “Adaptive Inventory Management Using RFID Data”, The International Journal of Advanced Manufacturing Technology, 2007, vol. 32, pp. 1045-1051.
Singh et al., “Versatility of Radio Frequency Identification (RFID) Tags in the Pharmaceutical Industry”, Instrumentation Science and Technology, vol. 36, pp. 656-663, 2008.
Summerfield, et al. “Evaluation of Medication Kit Processing Time Using Radio Frequency Identification (RFID) Technology”, Innovations in Pharmacy, 2015, vol. 6, No. 2, Article 199, 7 Pages.
Swedberg, Claire, “North Carolina Hospital Identifies Recalled Drugs Via RFID”, RFID Journal, http://www.rfidjournal.com/articles/view?10913, Aug. 14, 2013, 4 Pages.
Swedberg, Claire, “Tennessee Hospital Tracks High-Value Items”, RFID Journal, Aug. 5, 2009, pp. 2. <http://www.rfidjournal.com/articles/view?5106>.
Swedberg, Claire, “Zimmer Ohio to Use RFID to Manage Orthopedic Products”, RFID Journal, May 12, 2010, pp. 3. <https://www.rfidjournal.com/articles/pdf?7588>.
Tsai et al., “iMAT: Intelligent Medication Administration Tools” (Jul. 1, 2010), retrieved Aug. 21, 2017, 8 pages, available at http://ieeexplore.ieee.org/document/5556551/.
Tsai et al., “Smart Medication Dispenser: Design, Architecture and Implementation” (Sep. 27, 2010), retrieved Aug. 21, 2017, 12 pages, available at http://ieeexplore.ieee.org/document/5585838/.
Tzeng et al., “Evaluating the Business Value of RFID: Evidence from Five Case Studies,” International Journal of Production Economics, 2008, vol. 112, pp. 601-613.
“UPM Raflatac UHF EPC Gen2 RFID in Odin Solution at Johnson-Johnson DePuyIn-Q-Tel”, as posted Jun. 10, 2009, archived via archive.org <https://web.archive.org/web/20200316174347/https://www.youtube.com/watch?v=JWGyR8Bgfl8>, 1 page.
“Vizient, Inc. Awards Kit Check Contract for Pharmacy Kit Medication Inventory Tracking and Replenishment”, Press Release, http://www.prweb.com/releases/2016/09/prweb13691526.htm, Sep. 19, 2016, 3 Pages.
Wang et al., “Applying RFID Technology to Develop a Distant Medical Care Service Platform,” International Journal of Electronic Business Management, 2010, vol. 8, No. 2, pp. 161-170.
Wang et al., “RFID Applications in Hospitals: A Case Study on a Demonstration RFID Project in a Taiwan Hospital”, Proceedings of the 39th Hawaii International Conference on System Sciences, 2006, pp. 1-10.
Wasserman, Elizabeth, “Purdue Pharma to Run Pedigree Pilot”, RFID Journal, May 31, 2005, pp. 2. <http://www.rfidjournal.com/articles/view?1626>.
Complaint, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Dec. 1, 2017, 45 pages.
Exhibit L; Fagron Academy, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Dec. 1, 2017, 2 pages.
Defendant's Answer, Affirmative Defenses and Counterclaims to Plaintiff's Complaint, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jan. 2, 2018, 43 pages.
Plaintiff's Answer to Defendant's Counterclaims, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jan. 19, 2018, 14 pages.
Plaintiff Kit Check, Inc.'s Motion to Strike Insufficient Defenses, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jan. 19, 2018, 8 pages.
Defendant's First Amended Answer, Affirmative Defenses and Counterclaims to Plaintiff's Complaint, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Feb. 9, 2018, 43 pages.
Defendant's Memorandum in Opposition to Plaintiff Kit Check, Inc.'s Motion to Strike Insufficient Defenses, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Feb. 9, 2018, 6 pages.
Plaintiff's Answer to Defendant's First Amended Counterclaims, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Feb. 21, 2018, 14 pages.
Plaintiff Kit Check, Inc.'s Reply in Support of its Motion to Strike Insufficient Defenses, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Feb. 21, 2018, 6 pages.
Defendant Health Care Logistics, Inc.'s Motion for Judgment on the Pleadings Pursuant to Fed. R. Civ. P. 12(C), Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), May 25, 2018, 31 pages.
Exhibit A; U.S. Pat. No. 8,990,099, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), May 25, 2018, 12 pages.
Opinion & Order, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 13, 2018, 9 pages.
Defendant Health Care Logistics, Inc's Invalidity Contentions Pursuant to Local Patent Rule 103.4, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 18, 2018, 25 pages.
Exhibit 1; Initial Invalidity Claim Chart for U.S. Pat. No. 8,990,099, Kit Check, Inc. v. Health Care Logistics, Inc., Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 18, 2018, 51 pages.
Exhibit 2; Initial Invalidity Claim Chart for U.S. Pat. No. 9,058,413, Kit Check, Inc. v. Health Care Logistics, Inc., Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), June 18, 2018, 94 pages.
Exhibit 3; Initial Invalidity Claim Chart for U.S. Pat. No. 9,058,412, Kit Check, Inc. v. Health Care Logistics, Inc., Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 18, 2018, 83 pages.
Exhibit 4; Initial Invalidity Claim Chart for U.S. Pat. No. 9,734,294,Kit Check, Inc. v. Health Care Logistics, Inc., Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 18, 2018, 58 pages.
Exhibit 5; Initial Invalidity Claim Chart for U.S. Pat. No. 9,805,169, Kit Check, Inc. v. Health Care Logistics, Inc., Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 18, 2018, 251 pages.
Exhibit 6; Initial Invalidity Claim Chart for U.S. Pat. No. 9,037,479, Kit Check, Inc. v. Health Care Logistics, Inc., Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 18, 2018, 43 pages.
Exhibit 7; Initial Invalidity Claim Chart for U.S. Pat. No. 9,367,665, Kit Check, Inc. v. Health Care Logistics, Inc., Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 18, 2018, 109 pages.
Plaintiff Kit Check, Inc.'s Memorandum in Opposition to Defendant Health Care Logistics, Inc.'s Motion for Judgment on the Pleadings, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 29, 2018, 35 pages.
Exhibit 1; Non-Final Office Action for U.S. Pat. No. 8,990,099, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 29, 2018, 11 pages.
Exhibit 2; Notice of Allowance for U.S. Pat. No. 8,990,099, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 29, 2018, 15 pages.
Exhibit 3; Non-Final Office Action for U.S. Pat. No. 9,367,665, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 29, 2018, 12 pages.
Exhibit 4; Response to Non-Final Office Action for U.S. Pat. No. 9,367,665, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jun. 29, 2018, 18 pages.
Defendant Health Care Logistics, Inc.'s Reply in Support of Motion for Judgment on the Pleadings Pursuant To Fed. R. Civ. P. 12(C), Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jul. 20, 2018, 22 pages.
Exhibit A, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jul. 20, 2018, 43 pages.
Exhibit B; Plaintiff Kit Check, Inc.'s Disclosure of Asserted Claims and Infringement Contentions under Local Patent Rule 103.2, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jul. 20, 2018, 11 pages.
Plaintiff Kit Check, Inc.'s Motion to Strike Portions of Defendants' Reply or, in the Alternative, Motion for Leave to File a Sur-Reply, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Aug. 10, 2018, 6 pages.
Exhibit A; Plaintiff Kit Check, Inc.'s Sur-Reply in Opposition to Defendant's Motion for Judgment on the Pleadings, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Aug. 10, 2018, 5 pages.
Defendant Health Care Logistics, Inc.'s Memorandum In Opposition to Plaintiff Kit Check, Inc.'s Motion to Strike Portions of Defendant's Reply or, in the Alternative, Motion for Leave to File a Sur-Reply, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Aug. 31, 2018, 6 pages.
Plaintiff Kit Check, Inlf you'c.'s Reply in Support of its Motion to Strike Portions of Defendant's Reply or, in the Alternative, Motion for Leave to File a Sur-Reply, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Sep. 14, 2018, 7 pages.
Joint Claim Construction and Prehearing Statement, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Sep. 20, 2018, 21 pages.
Plaintiff Kit Check, Inc.'s Opening Claim Construction Brief, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Nov. 16, 2018, 50 pages.
Exhibit 1; Disputed Claim Terms Chart, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Nov. 16, 2018, 4 pages.
Declaration of Jeffrey Fischer, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Nov. 16, 2018, 24 pages.
Defendant Health Care Logistics, Inc.'s Opening Claim Construction Brief, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Nov. 16, 2018, 32 pages.
Exhibit 1002; File History of U.S. Pat. No. 9,367,665, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. PGR2019-00022, Nov. 30, 2018, 256 pages.
Exhibit 1003; Expert Declaration, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. PGR2019-00022, Nov. 30, 2018, 9 pages.
Exhibit 1013; Claim Construction Brief (Defendant), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. PGR2019-00022, Nov. 30, 2018, 32pages.
Exhibit 1014; Claim Construction Brief (Plaintiff), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. PGR2019-00022, Nov. 30, 2018, 50 pages.
Petition for Inter Partes Review of U.S. Pat. No. 8,990,099, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00376, Nov. 30, 2018, 42 pages.
Exhibit 1002; File History of U.S. Pat. No. 8,990,099, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00376, Nov. 30, 2018, 557 pages.
Exhibit 1003; Expert Declaration, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00376, Nov. 30, 2018, 9 pages.
Exhibit 1010; Claim Construction Brief (Defendant), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00376, Nov. 30, 2018, 32 pages.
Exhibit 1011; Claim Construction Brief (Plaintiff), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00376, Nov. 30, 2018, 50 pages.
Petition for Inter Partes Review of U.S. Pat. No. 9,058,412, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00385, Nov. 30, 2018, 75 pages.
Exhibit 1002; File History of U.S. Pat. No. 9,058,412, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00385, Nov. 30, 2018, 75 pages.
Exhibit 1003; Expert Declaration, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00385, Nov. 30, 2018, 9 pages.
Exhibit 1013; Claim Construction Brief (Defendant), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00385, Nov. 30, 2018, 32 pages.
Exhibit 1014; Claim Construction Brief (Plaintiff), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00385, Nov. 30, 2018, 50 pages.
Petition for Inter Partes Review of U.S. Pat. No. 9,058,413, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00387, Dec. 1, 2018, 73 pages.
Exhibit 1002; File History of U.S. Pat. No. 9,058,413, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00387, Dec. 1, 2018, 549 pages.
Exhibit 1003; Expert Declaration, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00387, Dec. 1, 2018, 9 pages.
Exhibit 1009; Children's Hospital Boston Joins Others Using RFID to Track Implantables, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00387, Dec. 1, 2018, 3 pages.
Exhibit 1012; The “Orange Book”, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00387, Dec. 1, 2018, 1103 pages.
Exhibit 1013; Claim Construction Brief (Defendant), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00387, Dec. 1, 2018, 32 pages.
Exhibit 1014; Claim Construction Brief (Plaintiff), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00387, Dec. 1, 2018, 50 pages.
Petition for Inter Partes Review of U.S. Pat. No. 9,805,169, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00388, Dec. 1, 2018, 76 pages.
Exhibit 1002; File History of U.S. Pat. No. 9,805,169, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00388, Dec. 1, 2018, 286 pages.
Exhibit 1003; Expert Declaration, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00388, Dec. 1, 2018, 9 pages.
Exhibit 1009; Claim Construction Brief (Defendant), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00388, Dec. 1, 2018, 32 pages.
Exhibit 1010; Claim Construction Brief (Plaintiff), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00388, Dec. 1, 2018, 50 pages.
Petition for Inter Partes Review of U.S. Pat. No. 9,367,665, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00394, Dec. 3, 2018, 69 pages.
Exhibit 1002; File History of U.S. Pat. No. 9,367,665, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00394, Dec. 3, 2018, 256 pages.
Exhibit 1003; Expert Declaration, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00394, Dec. 3, 2018, 9 pages.
Exhibit 1013; Claim Construction Brief (Defendant), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00394, Dec. 3, 2018, 32 pages.
Exhibit 1014; Claim Construction Brief (Plaintiff), Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00394, Dec. 3, 2018, 50 pages.
Plaintiff Kit Check, Inc.'s Notice of Filing Deposition Transcript of Jeffrey Fischer, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jan. 3, 2019, 3 pages.
Exhibit A; Deposition of Jeffrey Fischer, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jan. 3, 2019, 86 pages.
Plaintiff Kit Check, Inc.'s Responsive Claim Construction Brief, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jan. 3, 2019, 23 pages.
Exhibit A, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jan. 3, 2019, 43 pages.
Exhibit B; Deposition of Jeffrey Fischer, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jan. 3, 2019, 22 pages.
Defendant Health Care Logistics, Inc.'s Response to Plaintiff Kit Check, Inc.'s Opening Claim Construction Brief, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jan. 3, 2019, 22 pages.
Plaintiff Kit Check, Inc.'s Memorandum in Opposition to Defendant Health Care Logistics, Inc.'s Motion for Stay, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Feb. 11, 2019, 21 pages.
Exhibit 1; Defendant Health Care Logistics, Inc.'s Invalidity Contentions Pursuant to Local Patent Rule 103.4, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Feb. 11, 2019, 26 pages.
Defendant Health Care Logistics, Inc.'s Reply in Support of Motion for Stay, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Feb. 25, 2019, 10 pages.
Patent Owner's Preliminary Response, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00376, U.S. Pat. No. 8,990,099, Mar. 8, 2019, 26 pages.
Patent Owner's Preliminary Response, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00385, U.S. Pat. No. 9,058,412 B2, Mar. 8, 2019, 28 pages.
Patent Owner's Preliminary Response, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00387, U.S. Pat. No. 9,058,413 B2, Mar. 13, 2019, 28 pages.
Patent Owner's Preliminary Response, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00388, U.S. Pat. No. 9,805,169 B2, Mar. 13, 2019, 25 pages.
Patent Owner's Preliminary Response, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00394, U.S. Pat. No. 9,367,668 B2, Mar. 13, 2019, 28 pages.
Opinion & Order, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Mar. 14, 2019, 17 pages.
Joint Stipulation of Partial Dismissal Without Prejudice, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Apr. 16, 2019, 2 pages.
Transcript of Markman Hearing Proceedings, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), May 6, 2019, 74 pages.
Decision Denying Institution of Inter Partes Review 35 U.S.C. § 314, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00385, U.S. Pat. No. 9,058,412 B2, Jun. 3, 2019, 28 pages.
Decision Denying Institution of Inter Partes Review 35 U.S.C. § 314, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00385, U.S. Pat. No. 9,805,169 B2, Jun. 3, 2019, 20 pages.
Decision Denying Institution of Inter Partes Review 35 U.S.C. § 314, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00376, U.S. Pat. No. 8,990,099 B2, Jun. 4, 2019, 18 pages.
Decision Denying Institution of Inter Partes Review 35 U.S.C. § 314, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00387, U.S. Pat. No. 9,058,413 B2, Jun. 7, 2019, 26 pages.
Decision Denying Institution of Inter Partes Review 35 U.S.C. § 314, Health Care Logistics, Inc. v. Kit Check, Inc., Case No. IPR2019-00394, U.S. Pat. No. 9,367,665 B2, Jun. 11, 2019, 25 pages.
Stipulation and [Proposed] Order Granting Leave to Amend Plaintiff's Infringement Contentions and Defendant's Invalidity Contentions, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jul. 3, 2019, 3 pages.
Defendant Health Care Logistics, Inc.'s Motion for Leave to File Second Amended Answer, Affirmative Defenses, and Counterclaims, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jul. 17, 2019, 5 pages.
Exhibit A; Defendant's Second Amended Answer, Affirmative Defenses, and Counterclaims to Plaintiff's Complaint, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Jul. 17, 2019, 49 pages.
Request for Ex Parte Reexamination Under 35 U.S.C. 302-307 and 37 C.F.R. 1.510, U.S. Pat. No. 8,990,099 B2, U.S. Appl. No. 13/554,342, filed Jul. 25, 2019 in 80 pages.
Request for Ex Parte Reexamination Under 35 U.S.C. 302-307 and 37 C.F.R. 1.510, U.S. Pat. No. 9,058,412 B2, U.S. Appl. No. 14/603,730, filed Jul. 26, 2019 in 118 pages.
Request for Ex Parte Reexamination Under 35 U.S.C. 302-307 and 37 C.F.R. 1.510, U.S. Pat. No. 9,058,413 B2, U.S. Appl. No. 14/603,828, filed Jul. 25, 2019 in 151 pages.
Request for Ex Parte Reexamination Under 35 U.S.C. 302-307 and 37 C.F.R. 1.510, U.S. Pat. No. 9,805,169 B2, U.S. Appl. No. 14/701,958, filed Jul. 26, 2019 in 220 pages.
Request for Ex Parte Reexamination Under 35 U.S.C. 302-307 and 37 C.F.R. 1.510, U.S. Pat. No. 9,367,665 B2, U.S. Appl. No. 14/818,113, filed Jul. 26, 2019 in 164 pages.
Opinion & Order, Kit Check, Inc. v. Health Care Logistics, Inc. (involving U.S. Pat. Nos. 8,990,099, 9,037,479, 9,058,412, 9,058,413, 9,367,665, 9,734,294, and 9,805,169), Case No. 2:17-cv-01041-ALM-CMV (S.D. Ohio), Aug. 30, 2019, 26 pages.
Related Publications (1)
Number Date Country
20230402146 A1 Dec 2023 US
Provisional Applications (1)
Number Date Country
62883351 Aug 2019 US
Continuations (1)
Number Date Country
Parent 16985594 Aug 2020 US
Child 18151096 US